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Abstract 
 Adult newts are capable of completely regenerating lost structures including limb, tail, 
and spinal cord tissues after injury. A unique mammal capable of similar epimorphic 
regeneration is the Murphy Roths Large (MRL) mouse with the ability to fully close ear hole 
punctures. Examination of these mice revealed that they do not express the protein p21, a cyclin 
dependent kinase (CDK) inhibitor, which controls cell cycle progression from G1 to S phase by 
monitoring the cell for DNA damage. Knockout p21 mice were also able to fully close ear hole 
punctures validating the role of p21 in this phenomenon. Based on these findings, my research 
seeks to examine p21 during newt tail and caudal spinal cord regeneration. Since a lack of p21 
allows for regeneration in these mice, otherwise considered regeneration-incompetent, it is of 
interest to study p21 in the regeneration-competent newt, Notophthalmus viridescens. Using 
qPCR, I demonstrated that transcripts of a p21-like gene are significantly down-regulated at 14 
and 21 days post amputation. Initial Western blots indicated temporal changes in p21 expression 
across regeneration time points, but at a molecular weight smaller than the predicted 21kDa. The 
discrepancy in molecular weight led to mass spectrometry protein identification analysis that 
detected a p16-interacting protein in newt tail that shares 87.5% identity with the Xenopus p16-
interacting protein. p16 is also a CDK inhibitor, acting at the G1-S transition to specifically 
inhibit cyclin D and CDK4/6. Continued survey for p21 protein expression was unable to detect 
p21 within newt tissues tested. This outcome suggests either the tested antibodies are unable to 
cross-react with the newt p21 protein, or that it is expressed at very low levels in the newt 
making it virtually undetectable, or the newt lacks p21 protein like the MRL mouse. 5’-3’ RACE 
was unable to determine the newt-specific p21 sequence, but the newt Histone H3a gene was 
amplified and found to contain some sequence similarity to p21 in other species. This work 
represents the first attempt to study p21 gene and protein expression in regenerating newt caudal 
tail and spinal cord tissue. The novel finding of p16-interacting protein suggests the potential for 
alternative cell cycle regulation methods, via p16, previously thought to be lost in the newt. 
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1.1 General Introduction 
 Humans have been fascinated by the phenomenon of regeneration for centuries, with 
Spallanzani’s (1768) work detailing the regeneration of worms, snails, and amphibians like frogs 
and salamanders. His work represents the first account of complete limb and tail regeneration in 
the urodele amphibians: newts, axolotls, and salamanders. Following tail amputation, a thickened 
wound epidermis forms, allowing cells below this surface to proliferate and grow outwards into 
what is known as a blastema. This highly proliferative cell population associates with the 
regenerating spinal cord to elongate the regenerate and restore the tail to its original form and 
functional capacity. Mammals are capable of limited regeneration as seen with human embryonic 
digit tips and seasonal antler renewal in deer, but they typically lack the ability to fully 
regenerate lost or injured tissues (Allen et al., 2002; Bryant et al., 2002). Scar formation is 
thought to be the greatest physical barrier to successful regeneration in mammals, and it is the 
lack of a scar that aids in creating a permissive environment in urodeles (Whited et al., 2011).  
 One exemption to the finding that mammals are regeneration-incompetent is the Murphy 
Roths Large or MRL mouse, first created in 1979 by Murphy and Roths to study autoimmune 
deficiency disorders such as systemic lupus erythematosus. Serendipitously, while creating ear 
hole punches for identification purposes, it was observed that after approximately 30 days, the 
MRL mice no longer had holes in their ears when compared to wild-type mice that underwent 
the same procedure (Clark et al., 1998). Upon histological examination, punched ears developed 
a thickened wound covering, with cells below proliferating in a ring-like structure that resembled 
the blastema seen in regenerating urodele limbs and tails. Further study of this mouse model 
determined that in addition to regenerating lost ear tissue, the MRL mouse is capable of 
regenerating heart myocardium, central and peripheral nerves, brain, and other tissues (Buckley 
et al., 2012; Hampton et al., 2004; Leferovich et al., 2001; Thuret et al., 2012).  
 Additional examination of MRL mouse ear fibroblasts found that the cells showed a 
distinct G2/M (gap 2 and mitosis) bias and a high degree of DNA damage – two characteristics 
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common to the cells of classic regenerators, like hydra and newts, liver tissue, and mouse 
embryonic stem cells (Bedelbaeva et al., 2010; Buzgariu et al., 2014; Chuykin et al., 2008; 
Fausto and Webber, 1994; Tanaka et al., 1997). These traits are also indicative of a disruption in 
cell cycle regulation and led researchers to the discovery that the MRL mouse lacks the cyclin-
dependent kinase inhibitor (CKI) known as CDKN1A or p21 (Bedelbaeva et al., 2010). The 
G1/S (gap 1 and synthesis (replication) phase) transition of the cell cycle is controlled by p21 as 
the cells prepare for DNA replication. A lack of p21 in the MRL mouse allows for the increased 
proliferation required for regeneration, but causes the cells to acquire DNA damage from 
repeated rounds of replication without typical repair. The generation of p21 knockout mice, 
which were capable of regenerating to the same degree as the MRL mouse strain, demonstrated 
that a lack of p21 is sufficient to induce regeneration in an otherwise regeneration-incompetent 
wild-type mouse. Given that a lack of the cell cycle regulator, p21, confers regenerative 
capabilities in an otherwise regeneration-incompetent species, it is of great interest to determine 
if and how p21 is involved in the regenerative process in newts. 
1.2 Mammalian spinal cord wound healing versus newt caudal spinal cord and tail 
regeneration 
 Spinal cord injury (SCI) is characterized by toxic myelin breakdown, the influx of 
calcium ions, and the formation of a glial scar (Fitch et al., 1999; Silver and Miller, 2004). 
Following spinal cord injury, mammals undergo primary physical damage that is characterized 
by hemorrhage and local death of neurons, oligodendrocytes, and astrocytes at the injury site 
(Lee-Liu et al., 2013). The secondary chemical trauma involves extensive cell death via 
apoptosis caused by the increased local inflammation. Reactive astrocytes invade the injury site 
and a glial scar is formed, physically preventing regeneration (Lee-Liu et al., 2013). However, 
recent evidence suggests that following spinal cord injury in adult mice, axon regeneration can 
only occur when astrocyte bridges are present (Anderson et al., 2016). When astrocytic scar 
formation is prevented using a variety of transgenic loss-of-function strategies, a significant 
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decrease in axonal regrowth is seen, indicating that scar-forming astrocytes facilitate and support 
robust CNS axon regeneration (Anderson et al., 2016). Interestingly, in the period immediately 
following a SCI, reactive astrocytes serve a neuroprotective and reparative role, later becoming 
inhibitory in nature (Lee-Liu et al., 2013). These responses represent both the chemical and 
physical barriers that prevent mammalian spinal cord regeneration.  
 Central nervous system (CNS) axonal regenerative capacity exists in mammalian 
embryos during the early post-natal period, but is restricted as development proceeds (Lee-Liu et 
al., 2013).  The ability of newts to prevent normal scar formation after wounding establishes a 
permissive environment for regenerative pathways and molecules to initiate and maintain 
proliferation and outgrowth (Chernoff et al., 2002; Whited et al., 2011). CNS myelin in the newt 
does not inhibit nerve outgrowth, as it does in the mammal, and less secondary cell death occurs 
(Chernoff and Stocum, 1995). The newt also experiences calcium influx associated with 
glutamate excitotoxicity following injury, which would typically kill local neurons and 
oligodendrocytes, but the injury-reactive ependymal cells are capable of acting as a buffer by 
sequestering calcium and therefore protecting cells from processes that trigger secondary cell 
death in the mammal (Chernoff et al., 2003).   
 Ependymal cells, which line the central canal of the spinal cord in all vertebrates, are 
thought to contribute the most during spinal cord regeneration as they either maintain the 
embryonic characteristics of the neuroepithelia or establish the mesenchymal blastema through 
proliferation and tissue remodeling post injury (Chernoff and Stocum, 1995; Chernoff et al., 
2003). These neural progenitor cells acquire broad multipotency and are responsible for creating 
structures quite distinct from their embryological origins (Tanaka, 2003). The complete 
regeneration of the amputated tail relies upon the ependymal cells forming a hollow vesicle that 
remains continuous with the central canal of the cranial, intact spinal cord and provides a 
scaffold for nerve regeneration (Zukor et al., 2011). This hollow tube becomes the developing 
spinal cord within the regenerate and extends from the original amputation plane to the caudal 
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most tip of the blastema (Géraudie et al., 1988; Nordlander and Singer, 1978). Contact between 
the proliferating cells of the spinal cord and the tail stump lead to the formation of the wound 
epithelium, thereby driving the process of epimorphic regeneration in the newt tail (Chernoff and 
Stocum, 1995). Epimorphic regeneration involves the local dedifferentiation of tissues at the 
injury site and recruitment of progenitor cells to this region, which then undergo extensive 
proliferation to form a heterogeneous mass of cells (known as a blastema), and eventually 
differentiate to replace the missing structures (Gawriluk et al., 2016; Stocum and Cameron, 
2011). This intricate process of caudal tail and spinal cord regeneration in the newt is an 
important model to study given that it involves extensive CNS regeneration in addition to 
epimorphic tissue regeneration of a variety of non-neural structures. 
1.3 Stages of tail regeneration in the newt, Notophthalmus viridescens  
 Tail regeneration follows a rostrocaudal pattern and has been described as occurring in 
five distinct stages, each defined by key morphological and cellular features (Iten and Bryant, 
1976). Figure 1.1A-D includes representative histological sections from stages I to IV, 
respectively. Stage I (Figure 1.1A), representing 1-5 days post amputation (dpa), is characterized 
by the formation of a thickened wound epithelium that covers the amputation site and the lack of 
a basement membrane below the wound epidermis. Breakdown of the basement membrane is 
related to the absence of tissue inhibitors of metalloproteinases (TIMPs) and the related 
significant increase of matrix metalloproteinases (MMPs), which are found to be highest at two 
to four weeks post lesioning (Chernoff et al., 2003). The posterior tip of the severed spinal cord 
retracts and remains proximal to the level of amputation, and the spinal cord meninges extend to 
make contact with the wound epidermis (Iten and Bryant, 1976). Mitotic figures are not observed 
in the ependymal cells at this time.  
 Stage II (Figure 1.1B), encompassed by 6-11 dpa, is the point at which the tail stump 
takes on a dome shape as it starts out swollen and translucent with a blister-like appearance 
relative to the firm stump epidermis (Iten and Bryant, 1976). Dead cells and tissue debris are  
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Figure 1.1: Stages of Tail Regeneration in the Adult Newt, Notophthalmus viridescens. 
Figured adapted from Iten and Bryant (1976). A) Frontal section through a regenerate 2 dpa 
featuring tissue debris (arrow) below epidermis (E), degenerating muscle fibers (dM), and the 
posterior spinal cord (Sc). B) Median frontal section of a regenerate 10 dpa with the terminal 
vesicle (Tv) of the ependymal tube present in the accumulation blastema (B). A transected 
vertebra (V) is also highlighted. C) Frontal section through the spinal cord (Sc) of a 
regenerate 13 days post amputation. D) Median frontal section of a regenerate 20 dpa 
featuring the distal half of the cartilaginous rod (C), proximal and distal portions of the 
regenerating spinal cord (Sc), a myomere (My) amongst new muscle fibers, the neural arch of 
regenerating vertebra (Na), and spinal ganglia (Sg) surrounding the spinal cord. 
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found within the wound epidermis and blastema cells are first seen accumulating beneath the 
regenerate tip. The ependymal tube is formed at this stage caudal to the amputation plane. 
Ependymal cells exhibit a high degree of mitosis with cells immediately rostral to the amputation 
site being the area of greatest proliferation (Egar and Singer, 1972; Nordlander and Singer, 
1978). Bromodeoxyuridine (BrdU), a thymidine analog that becomes incorporated into the DNA 
and is used to monitor cell proliferation, indicated that the high levels of mitosis in ependymal 
cells are also associated with the terminal bulb, with cells distributed along the length of the tube 
providing a source for new, differentiated neurons (Benraiss et al., 1999; Chernoff et al., 2003). 
Mesenchymal-like cells surrounding the early ependymal tube are thought to later give rise to 
muscle and bone in the regenerated tail (Géraudie et al., 1988). The epidermis is innervated, 
spinal ganglia around the amputation site are growing into the accumulation blastema, and 
osteoclasts are observed surrounding transected vertebra. 
 Stage III (Figure 1.1C) from days 11 to 15 encompasses a distinct change in the tail 
regenerate from dome-shaped to cone-shaped. It is now possible to observe vascularization in the 
tail, and dead cells and tissue debris have been cleared from the thinning epidermis (Iten and 
Bryant, 1976). Chondrogenesis is prevalent at this stage, with the developing cartilaginous rod, 
from which the centrum and new vertebral arches will be derived, is located beneath the cord 
(Géraudie et al., 1988; Iten and Bryant, 1976). The terminal vesicle of the spinal cord is close to 
the tip of the regenerating tail, and both myoblast and myotube formation is also occurring at this 
stage. 
 Stage IV (Figure 1.1D) covers regeneration from days 16 to 28. At this point, extensive 
differentiation begins within the tail regenerate, including a gradient of muscle differentiation 
from the stump. The cartilaginous rod continues to elongate and mature in association with the 
spinal cord. Numerous mitotic figures are observed along the length of the regenerated 
ependymal tube, with the establishment of a meningeal layer beginning at the proximal spinal 
cord (Iten and Bryant, 1976). New neurons are created within the cord itself and spinal cord 
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regeneration within the tail involves the formation of new segmental nerves and ganglia (Egar 
and Singer, 1972; Géraudie et al., 1988; Nordlander and Singer, 1978). Peripheral nervous 
system (PNS) and CNS neurons are produced from the ependymal tube with three week old tail 
regenerates showing proliferative ependymal cells directly giving rise to glia and neurons 
(Chernoff et al., 2003). Blastema cells have become confined to the distal tip of the regenerate, 
condensed between the epidermis and the cartilaginous rod. Spinal ganglia are observed as pairs 
lateral to the regenerated spinal cord.  
 Finally in stage V (no image shown), the regenerating tail undergoes full differentiation 
of remaining tissues. Fine morphological features of the vertebra can be described at this stage. 
Spinal ganglia are located laterally and ventrally to the regenerated spinal cord and muscle fibers 
are present along the length of the regenerate (Iten and Bryant, 1976).  
 One exceptional mammal, known as the MRL mouse, is capable of regenerating a variety 
of tissues in a mechanism that resembles this epimorphic regeneration seen in the newt.   
1.4 The MRL mouse: A mammalian model capable of regeneration 
 The MRL or Murphy Roths Large mouse was originally created as a mouse line to study 
autoimmune deficiency disorders, specifically systemic lupus erythematosus (Murphy and Roths, 
1979). The mouse line was created from crossing the following strains: AKR, an albino mouse 
strain with a high incidence of lymphatic leukemia; C3H, an inbred mouse strain with a high 
incidence of mammary tumors; C57BL/6, or C57 black 6, a common inbred strain of lab mice 
that is refractory to tumors; and LG/J, or Large, a mouse strain with a compromised immune 
system that produces antinuclear antibodies and rheumatoid factors (Jackson Laboratory). The 
last strain, LG/J, contributed to 75% of the MRL mouse’s genome and is the only strain included 
that has regenerative capabilities. Importantly, studies by Kench et al. (1999) demonstrated with 
reciprocal bone marrow transplants that the ability of the MRL mouse to regenerate is 
independent of its autoimmunity. The MRL mouse possesses many characteristics that resemble 
a microenvironment conducive for tumor formation, however the strain has a low incidence of 
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cancer (Heber-Katz and Naviaux, 2015).  
 When ear hole punctures were created for identification purposes, it was observed that 
these mice were able to fully close the holes when compared to wild-type mice (Clark et al., 
1998). Ear punctures close in approximately 4 weeks without scarring and normal tissue 
architecture is reestablished (Clark et al., 1998). Upon closer inspection, it was determined that 
this closure was facilitated by a highly proliferative cell population mimicking a blastema 
(Bedelbaeva et al., 2010). This type of regeneration is similar to epimorphic regeneration in 
urodele species such as the newt because of the prompt re-epithelialization of the wound surface 
post injury, the formation of a blastema, and the lack of scar formation during healing (Arthur 
and Heber-Katz, 2011). The circular blastema formed following breakdown of the basement 
membrane allows local cells to dedifferentiate, proliferate, and eventually re-differentiate into 
new mouse ear tissue (Figure 1.2).  
 The discovery of the MRL mouse’s ability to regenerate lost ear tissue spurred further 
research into the extent of the mouse’s capacity for regeneration. In MRL mice, innervated ears 
close almost completely by day 50, but denervated ears become increasingly necrotic with the 
wound spreading to the ear tip (Buckley et al., 2012). It has since been determined that the MRL 
mouse is also capable of regenerating heart and brain tissue (Cheng et al., 2013; Hampton et al., 
2004; Leferovich et al., 2001; Tucker et al., 2008). Except for rabbits, which have been found to 
close small ear hole punctures over a 6-8 week period, the MRL mouse is unique in its ability to 
fully close ear hole punctures in addition to regenerating other tissues (Grimes, 1972; Grimes 
and Goss, 1970). These mice exhibit high levels of DNA damage, an accumulation of cells at the 
G2/M stage of the cell cycle, and a lack of p21 protein in both uninjured and injured tissues 
(Bedelbaeva et al., 2010). The initial finding of cell accumulation in the G2/M phase indicated a 
possible G1 checkpoint deficiency and led to the specific studies of p21. This G2/M bias, 
characterized by a lack of p21, leads to unscheduled entry into the synthesis phase of the cell 
cycle and is common to regenerators as it creates an environment conducive to a proliferative  
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Figure 1.2: The MRL mouse is able to fully regenerate ear hole punctures in a 
mechanism similar to epimorphic regeneration in the newt. Figure adapted from Heber-
Katz et al., (2012). Ai) A control, wild-type mouse (C57BL/6) with initial ear hole punctures 
and the same ear (Aii) 30 days later. Bi) An MRL mouse ear at the time of ear hole puncture 
and 30 days later (Bii) showing a closed hole where the puncture used to be. 
C-F) Histological changes in the regenerating MRL mouse ear. C) At 1 day post injury (dpi), 
inflammatory cells line up at the edge of the ear punch (arrows). D) Re-epithelialization of the 
wound surface is complete by 2 dpi, forming a wound epidermis similar to a regenerating 
newt tail. E) At 5 dpi, hair follicles begin to form within the new epidermis (uppermost arrow) 
and cells begin to accumulate in a blastema-like structure beneath the wound epidermis (two 
lower arrows). F) Ten days post injury the ear tissue contains a highly proliferative cell 
population (arrow) like that of a blastema, which will eventually close the ear hole by 
replacing the lost tissue. 
 
 11 
response (Bedelbaeva et al., 2010).  
 Through Western blotting, it was determined that MRL mice do not express the cell cycle 
regulator p21, and when the p21 gene was ablated in wild-type mice, they too possessed the 
ability to regenerate lost ear tissue (Bedelbaeva et al., 2010). This demonstrated that a lack of p21 
confers regenerative abilities in an otherwise regeneration-incompetent species.  
1.5 Cell cycle regulation and p21 
 The cell cycle contains four main stages (Figure 1.3A) with a quiescent stage, G0; G1, 
the initial gap before the cell is ready to synthesize DNA; S-phase, DNA synthesis by 
replication; G2, the second gap during which the cell prepares to divide; and M, the point at 
which the cell undergoes division through mitosis (Besson et al., 2008; Pajalunga et al., 2008; 
Vermeulen et al., 2003). p21, also known as CDKN1A (Cyclin-dependent kinase inhibitor 1A), 
belongs to the Cip/Kip (cyclin inhibitor protein/kinase inhibitor protein) family of CDK (cyclin 
dependent kinase) inhibitors and acts primarily in the G1 phase to prevent cell cycle progression 
by binding directly to cyclin-CDK complexes (Albrecht et al., 1997; Harper et al., 1995). The 
Cip/Kip family includes p21, p27, and p57, all of which contain a conserved amino-terminal 
CDK inhibitory domain of approximately 80 amino acids (Niculescu et al., 1998). 
 p21 exhibits preferential binding to the CDK4/6-cyclin D and CDK2-cyclin E complexes 
causing deformation of and interference with the CDK active site (Niculescu et al., 1998). The 
related CDK inhibitor, p16 (CDKN2A), is derived from the INK4a locus, and specifically targets 
D-type cyclins and CDK4/6, rendering the retinoblastoma (pRb) protein inactive (Liggett and 
Sidransky, 1998; Lukas et al., 1995; Serrano, 1997; Serrano et al., 1993). p16 can only cause cell 
cycle arrest up until a certain stage in late G1 that most likely correlates with a checkpoint 
executed by the cyclin D:CDK4/6 complexes (Lukas et al., 1995). The p21 gene contains a p53 
binding site in its promoter, allowing p53 to transcriptionally activate p21 gene expression 
(Besson et al., 2008). p21 is also capable of preventing DNA synthesis by binding to 
proliferating cell nuclear antigen (PCNA), an interaction that allows for cell cycle arrest in S  
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!  Figure 1.3: The cell cycle and mechanisms triggering the G1/S transition. A) The cell 
cycle consists of four main stages: G1, S, G2, and M with a quiescent G0 stage. The red box 
highlights G1 and the yellow star marks the G1/S transition. B) As the cell prepares to 
transition from G1 to S phase, cyclins and CDKs begin to associate, leading to the 
phosphorylation of retinoblastoma protein (pRb). Phosphorylated pRb releases the 
transcription factor E2F, allowing the E2 factor to enter the nucleus and increase its own 
expression in an autocrine fashion, while enhancing the expression of cyclins, ultimately 
driving the transition to the synthesis phase. 
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phase (Arthur et al., 2010). PCNA enhances DNA polymerase α activity, and in p53-deficient 
cells can trigger both G1 and G2 arrest when activated by p21 (Cayrol et al., 1998; Noda et al., 
1994).  
 In order to proceed through the G1-S checkpoint and enter the synthesis phase of the cell 
cycle, the concentration of cyclins:CDKs must exceed the available p21 in order to overcome 
this inhibitory effect (Figure 1.3B). The increasing concentration of cyclins and CDKs triggers 
the phosphorylation of retinoblastoma (pRb) protein, subsequently removing pRb protein’s 
inhibition of the transcription factor E2F (Lukas et al., 1995; Niculescu et al., 1998). The release 
of E2F allows its translocation to the nucleus, at which point it acts in both a paracrine and 
autocrine fashion to increase the expression of the cyclins D and E, and itself. This increased 
expression of cyclins promotes saturation of p21 with cyclin:CDK complexes, triggering the 
transition to S phase by overcoming p21-specific inhibition at the G1-S checkpoint.  
 The classical pathway of cell cycle arrest leads to the activation of the tumor suppressor 
gene p53 following the detection of DNA damage in the cell. In severely damaged cells, p53 
activates the apoptotic pathway. In normal cells, CDKs predominantly exist in quaternary 
complexes each containing a CDK, cyclin, PCNA, and p21 protein (Xiong et al., 1993). The 
concentration of p21 in this association has implications for function, with complex assembly 
being triggered at lower concentrations and inhibition observed at higher concentrations. In a 
p53-dependent mechanism, p21 expression is triggered, causing it to bind with cyclin:CDK 
complexes, preventing the phosphorylation of pRb protein and ultimately maintaining the 
transcriptional repression of E2F (Pajalunga et al., 2008). The progression of the cell cycle into 
S-phase is blocked by p21 at the G1-S checkpoint until all detected DNA damage is repaired. In 
normal cycling cells, p21 mRNA is present across the cell cycle with the highest levels seen at 
G1 and levels re-accumulate as cells complete DNA synthesis and enter G2 (Li et al., 1994). 
Similarly, p21 protein is expressed throughout the cell cycle with a rapid turnover of protein 
synthesis (Li et al., 1994). The lack of p21 expression detected in the MRL mouse leads to 
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unscheduled entry into S phase of the cell cycle, enhancing proliferation (Bedelbaeva et al., 
2010). This increase in proliferation is associated with an increase in apoptosis to maintain the 
high cell turnover rate and clear old cells (Bedelbaeva et al., 2010; Mirzayans et al., 2012; 
Piccolo and Crispi, 2012).  
 p21 can also be activated in a variety of p53 independent ways including cytokine 
production, cell adhesion events, and during the processes of cell growth and differentiation 
(Arthur et al., 2010; Cayrol et al., 1998; Macleod et al., 1995; Niculescu et al., 1998; Parker et 
al., 2015). In addition to its repair function, p21 expression is associated with cellular senescence 
in that its inhibition of cell proliferation is directly linked to the permanent withdrawal from the 
cell cycle (Arthur and Heber-Katz, 2011; Brugarolas et al., 1995). The localization of p21 can 
also impact the functionality in that cytoplasmic localization is associated with cell growth and 
survival as p21 acts as a chaperone for cyclin E, whereas the predominant nuclear localization 
leads to the canonical function of inhibition of cell division and growth (Gawriluk et al., 2016; 
Piccolo and Crispi, 2012). Diminished p21 levels are suggestive of significant, widespread DNA 
damage as the cell cycle proceeds without repair and arrests in G2 instead of the predicted G1 
arrest. 
1.6 Cell cycling and regulation in common model organisms and regeneration-competent 
species 
 
 In sponges, the ability to heal is associated with the activation of a DNA damage 
response mechanism that leads to an increase in single strand DNA breaks (Arthur et al., 2010; 
Bedelbaeva et al., 2010). The freshwater polyp, Hydra, a classic model of regeneration, 
possesses three adult stem cell populations along the central body column that are capable of 
self-renewal (Buzgariu et al., 2014; David and Gierer, 1974). Myo-epithelial cells (MECs) 
revealed a very short G1 phase and an extended G2 phase ranging from 24-72 hours, which is 
uncommon to adult animal cells that typically experience a fixed and short G2. Interstitial cells 
(ISCs) in the gastric region alternate between the S and G2 phases without pausing in G1. These 
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cells share properties with mammalian embryonic stem cells (ESCs) that have a short G1 due to 
the loss of a G1/S checkpoint and subsequently pause in G2 (Chuykin et al., 2008). Cycling 
progenitor cells are susceptible to pro-apoptotic factors, making cells paused in G2 resistant to 
these agents. Prolonged pausing in G2 may enhance the DNA repair program and ultimately aid 
in limiting extensive cell death in the regenerating Hydra and other regeneration-competent 
species (Buzgariu et al., 2014). 
 Planaria, another excellent model organism for regenerative studies given their simple 
body plan and stem cell like neoblasts, possess a single p53 family member (Smed-p53) that is 
chiefly expressed in newly made, postmitotic stem cell progeny (Pearson and Sánchez Alvarado, 
2010). When RNAi targeted Smed-p53, increases in the stem cell population were observed and 
hyperproliferation occurred, but at the expense of daughter cell differentiation, thereby 
preventing self-renewal (Pearson and Sánchez Alvarado, 2010). This observation demonstrates 
the tumor suppressor-like function of Smed-p53, similar to human p53, suggesting that p53 
expression is important for maintaining the planarian stem cell population. Drosophila p53 
(Dmp53) shares many sequence features with human p53 including binding sites and the ability 
to induce apoptosis through the DNA damage response pathway when Dmp53 is overexpressed 
(Ollmann et al., 2000). Inhibition of Dmp53 renders cells resistant to X-ray induced apoptosis, 
suggesting an ancestral pro-apoptotic function for p53 (Ollmann et al., 2000). 
 Apoptosis, or programmed cell death, is essential in the early stages of Xenopus tail 
regeneration as the inhibition of caspase-3, the frequently activated death protease, prevents 
regeneration. Without apoptosis, the regenerate fails to induce proliferation (Tseng et al., 2007). 
Similarly, apoptosis is essential to the process of spinal cord regeneration in the brown ghost 
knifefish, Apteronotus leptorhynchus, as it minimizes inflammation of damaged cells at the 
lesion site (Sîrbulescu and Zupanc, 2009). The intensity of apoptosis detected during the cell 
replacement phase is equal to levels present at baseline within intact tissues, suggesting that cells 
are primed to respond to a potential injury (Sîrbulescu and Zupanc, 2009).  
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 Upon exposure to gamma irradiation, an accumulation of p53 protein is seen in the gut 
epithelium, liver, pancreas, and brain tissues of zebrafish (Lee et al., 2008). In addition to 
increased p53 expression in the zebrafish, active caspase-3 was detected indicating an elevated 
apoptotic response and transcriptional up-regulation of p21 was observed (Lee et al., 2008). 
Further studies with p53 deficient and knockdown zebrafish embryos determined that p21 is a 
downstream target of p53 as revealed by relative p21 mRNA levels (Langheinrich et al., 2002). 
Together, these findings indicate similarities in cell cycling between the MRL mouse and 
regeneration-competent species, such as sponges and Hydra, while highlighting the conserved 
roles of p53 and apoptosis across a variety of invertebrate and vertebrate species.  
1.7 Cell cycling and regulation in the axolotl and newt 
 Urodele amphibians are capable of undergoing multiple rounds of cell cycle re-entry 
without increased susceptibility, but rather, enhanced resistance to tumor formation. For 
example, newt limb blastema cultures can cycle through nearly 200 generations without showing 
signs of senescence (Ferretti and Brockes, 1988). The reentry response underlies the ability to 
dedifferentiate during regeneration. Upon amputation, dedifferentiation and entry of mesodermal 
cells into the cell cycle occurs leading to DNA replication and mitosis. Newt limb blastema cells 
spend approximately 40 hours in S phase making up 83% of the cell cycle (McCullough and 
Tassava, 1976). Tritiated (3H) thymidine labeling, which is incorporated into the DNA and can 
be used to determine the rate of replication, showed approximately 30% of blastema cells are 
labeled by the accumulation blastema stage, but continuous studies have indicated that as high as 
80% of the cells can be labeled (McCullough and Tassava, 1976; Mescher and Tassava, 1975). 
Not all cells of the blastema are actively cycling, instead a number of cells exist in a transient 
quiescent state with a population size dictated by the degree of innervation present in the 
regenerating limb (Tassava et al., 1987). In the absence of nerves, cells arrest in G2, whereas 
cells arrest in G1 without an associated wound epithelium (Tassava and Mescher, 1976; Tassava 
et al., 1987). Most cells involved in forming the accumulation limb blastema are thought to arrest 
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in G2 after completing DNA replication, and remain there until the growth phase begins, based 
upon the blastema cell profile of high levels of DNA replication and very low levels of mitosis 
(Mescher and Tassava, 1975).  
 Salamander myotubes remain responsive to proliferative cues because they are able to re-
enter the cell cycle upon serum stimulation either in culture or after implantation into the 
regenerating limbs (Tanaka et al., 1997). Re-entry into the cell cycle is dependent on the 
phosphorylation of retinoblastoma protein and the down-regulation of p53 activity. Sustained 
ERK1/2 (extracellular regulated kinase) activation is also essential to this process as it is directly 
responsible for the decrease in p53 and promotes S-phase re-entry of newt A1 myotubes (Yun et 
al., 2014). The continued activation of ERK has also been implicated as a negative regulator of 
antiproliferative genes, such as p21, until the onset of S phase to allow for G1 phase progression 
(Yamamoto et al., 2006).  
 Newt A1 myotubes exhibit basal levels of p53 expression with little change post 
exposure to 10 Gy (Gray) of irradiation (Linklater, 2011). When p53 expression was blocked in 
the axolotl using the p53-specific inhibitor, pifithrin-α, limb regeneration was inhibited (Villiard 
et al., 2007). More detailed studies revealed that p53 expression in the limb blastema is under 
tight regulation, with an initial decrease in expression required for the formation of the blastema, 
followed by an eventual up-regulation to basal levels for the process of redifferentiation (Yun et 
al., 2013). Protein levels of p53 were significantly decreased in mid-bud blastemas and 
differentiated muscle and epidermis showed strong p53 expression, but no change in p53 mRNA 
expression occurred, suggesting that p53 undergoes post-transcriptional regulation (Yun et al., 
2013). Cloning of the axolotl p53 gene allowed for sequence comparison to human p53 that 
revealed multiple amino acid changes that are thought to have evolved specifically for 
maintaining tumor suppressor ability in the regeneration-competent species (Villiard et al., 
2007). It is further speculated that these changes to p53 may aid the axolotl in withstanding 
drastic variations in both oxygen level and temperature within their environment (Villiard et al., 
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2007). Perhaps a more extreme example of evolutionary distinct genes is the salamander-specific 
gene, Prod1, a retinoid-inducible gene expressed during newt limb regeneration (Garza-Garcia et 
al., 2010; Geng et al., 2015). With no ortholog present in Xenopus or zebrafish, Prod1 is an 
orphan gene that either evolved independently in the newt, or was retained in newts and lost in 
other tetrapods over time (Geng et al., 2015).  
 An axolotl EST (expressed sequence tag) sequencing project detected a variety of cell 
cycle inhibitor contigs including p27, p28, and p57 (Habermann et al., 2004). Mass spectrometry 
analysis of proteome changes during axolotl limb regeneration determined that the significant 
up-regulation of the cell cycle-related oncoprotein, ecotropic viral integrative factor 5 (Evi5), is 
associated with the low mitotic index observed during limb blastema formation (Rao et al., 
2009). In early G1, the centrosomal protein Evi5 accumulates within the nucleus to stabilize the 
protein Emi1, an association that is later responsible for preventing premature entry into mitosis. 
The strong expression of Evi5 in the axolotl limb blastema is thought to restrict dedifferentiated 
cells from entering mitosis, instead pausing in G2 until sufficient numbers of cells exist to form 
the accumulation blastema (Rao et al., 2009; Stocum and Cameron, 2011).  
  The administration of human p16 to urodele regenerating systems is a common method 
for understanding the function of cell cycle inhibition. When human p16 was expressed in newt 
myotubes, BrdU uptake was abolished after serum stimulation, establishing the importance of 
retinoblastoma protein phosphorylation for cell cycle re-entry (Tanaka et al., 1997). It has been 
proposed that the INK4a locus first arose in mammals and is not actually present in salamanders, 
contributing to the restricted regenerative capacity of mammals (Pajcini et al., 2010). The 
induced over-expression of p16 suppresses axolotl spinal cord regeneration by reducing the 
ependymal tube length (Khattak et al., 2013). p16 may be required for normal development, but 
the induction of p16 just before the onset of regeneration negatively impacts the regenerative 
process, suggesting that a lack of p16 gene products allows for robust regeneration in the axolotl 
(Khattak et al., 2013). Overall, this collection of research indicates that cell cycle regulation, via 
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a number of different mechanisms, is an integral part of regeneration in urodele amphibians like 
axolotls and newts.  
1.8 p21 in mammals and conflicting roles in mammalian regeneration 
 In mouse tissues, p21 is not expressed at appreciable levels in heart, liver, or lung tissues 
until after exposure to gamma irradiation. Strong p21 expression often correlates with an absence 
of apoptosis (Bouvard et al., 2000). In the adult mouse, expression of p21 is restricted to 
terminally differentiating cells, with the highest expression levels detected in tissues such as the 
skin and gastrointestinal tract lining that experience a high cell turnover rate (Boonstra, 2003). 
Terminally differentiated cells are defined by specialized functions, which are acquired from 
tissue specific gene expression associated with irreversible growth arrest (Tanaka et al., 1997). 
Wild-type mice demonstrate expression of p21 in the thymus, spleen, testes, and brain with very 
high levels in the small intestine (Macleod et al., 1995). No induction of p21 is seen in tissues of 
irradiated p53-deficient mice indicating that p53 is essential to triggering the DNA damage 
response (Macleod et al., 1995). p21 acts to inhibit cell proliferation in order to protect cells from 
undergoing stress-induced apoptosis and contributing to oncogenesis (Boonstra, 2003). 
 p21 is essential to the in vivo healing process of muscle injury as p21 knockout mice 
experienced delayed muscle regeneration (Chinzei et al., 2015). The p21 deficiency extended the 
length of the cell cycle and led to increased muscle cell proliferation, but the expression of 
muscle synthesis genes was too low, halting muscular differentiation (Chinzei et al., 2015). 
Similar to this finding, after dorsal hemisection of the thoracic spinal cord in rats, the 
administration of cytoplasmic p21 to the injury site leads to increased axonal regeneration, 
hindlimb functional recovery, and inhibition of cavity formation within the spinal cord (Tanaka 
et al., 2004). The increased local expression of p21 prevented apoptosis and macrophage 
infiltration to the injury site, while enhancing immunoreactivity to glial fibrillary acidic protein 
(GFAP) indicating the presence of astrocytes that contribute to wound healing in this context 
(Tanaka et al., 2004). As mentioned previously, the specific cytoplasmic localization of p21 in 
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this context implies that the functionality of p21 changes from inhibitory to promoting cell 
growth and survival instead (Piccolo and Crispi, 2012).  
 Conversely, a lack of p21 expression is essential for successful liver regeneration as 
increased p21 protein levels are correlated with impaired hepatocyte proliferation (Stepniak et 
al., 2006). The up-regulation of p21 protein leads to increased phosphorylation of p38, a stress 
kinase that stabilizes p21, thereby prolonging p21 expression (Stepniak et al., 2006). Recent 
work by Gawriluk et al., (2016) has identified successful ear hole closure in the African spiny 
mouse, Acomys cahirinus, and the New Zealand white rabbit, Oryctolagus cuniculus, confirming 
prior findings of rabbit ear hole closure, and identifying this epimorphic regenerative ability in 
other mammals (Grimes and Goss, 1970). Following transcriptome, histological, and cell cycle 
analyses, A. cahirinus demonstrated the formation of a newt-like blastema in regenerating ear 
tissue, with no nuclear localization of p21 detected in proliferating mesenchymal cells (Gawriluk 
et al., 2016). Mus musculus controls run in parallel to A. cahirinus were unable to regenerate, 
producing only scarred ear tissue and demonstrating strong nuclear localization of p21 that 
increased over the time course studied (Gawriluk et al., 2016).  
 The presence of p21 expression in cases of muscle and spinal cord regeneration represent 
tissue-specific examples that require p21 for successful regeneration. In contrast, the absence of 
p21 during liver regeneration and in the blastema-mediated epimorphic regeneration of ear tissue 
in the African spiny mouse indicate that a lack of p21 in these instances plays a similar role to 
p21 in the regeneration-competent MRL mouse. 
1.9 p21 in regeneration-competent and related newt species 
 Xenopus possess 3 CDK inhibitors, including p16Xic2, which is the structural and 
functional ortholog of human p21 (Daniels et al., 2004). The carboxy terminal region shows 
good homology with the PCNA binding domain of human p21, suggesting that p16Xic2 may 
regulate the cell cycle by changing PCNA activity in addition to inhibiting CDK and cyclin 
complexes (Daniels et al., 2004). p16Xic2 is found in Xenopus somites, tail bud, lens, and 
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cement gland and like mammalian p21, Xic2 expression is greatly induced post irradiation (Zhu 
et al., 2013). 
 Work in the marbled newt, Triturus marmoratus marmoratus, which experiences limited 
regeneration in response to injury, examined the expression of p53, p21, and pRb across the 
annual testicular cycle (Towle, 1901; Weismann, 1893). Maturation of testis is a synchronous 
and well-controlled process defined by three stages: proliferation, spermiogenesis, and 
quiescence (Ricote et al., 2002). The strongest expression of p21 protein was observed during the 
quiescent phase of the cycle, as it had previously been shown in rat and mouse testicular cells, as 
no cell proliferation is occurring at this stage (Ricote et al., 2002). In a similar cyclical fashion, 
the circadian clock is responsible for daily timing of the cell cycle, specifically restricting S 
phase and M phase to certain times of the day (Laranjeiro et al., 2013; Peyric et al., 2013).  
 The cell cycle regulators, p21 and the related p20, are expressed in the brain and gut of 
developing zebrafish and their differential patterns of expression regulate the daily timing of 
entry into S phase (Laranjeiro et al., 2013). These examples indicate the presence of the cell 
cycle inhibitor, p21, in regeneration-competent species such as Xenopus and zebrafish, and 
demonstrate a role for p21 in the regeneration-compromised newt species, T. marmoratus, 
suggesting the cell cycle regulator, p21, is conserved in other vertebrates beyond mammals.  
1.10 Objectives 
 Given that the unique abilities of the MRL mouse to regenerate a variety of tissues can be 
attributed directly to a lack of, or down-regulation of the cell cycle regulator, p21, it is 
fundamental to understand if a similar mechanism exists in regeneration-competent species. This 
question forms the basis of my thesis, which seeks to examine the role of p21 during caudal 
spinal cord and tail regeneration in the Eastern Red-Spotted newt, Notophthalmus viridescens. 
Using real-time quantitative polymerase chain reaction (RT-qPCR), Western blotting, and 5’-3’ 
Rapid Amplification of cDNA end (RACE) techniques, I sought to provide novel data regarding 
the expression of p21 in the newt. Determining the newt-specific p21 sequence would allow for 
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the examination of potential evolutionary differences in cell cycle regulation and its role in 
regeneration. Overall, this collection of work represents the first exploration of p21 expression in 
the regeneration-competent newt.
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CHAPTER TWO: 
p21 is down-regulated and a p16-interacting protein, not p21, is detected during caudal 
spinal cord and tail regeneration 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 24 
Abstract 
 
 Regeneration is considered a unique characteristic of urodele amphibians such as newts 
and salamanders. The ability to completely regenerate lost structures including the limbs, spinal 
cord, and parts of the heart as an adult makes the newt, Notophthalmus viridescens, a useful 
model organism to study the process. Typically, mammals are unable to undergo epimorphic 
regeneration, however, the MRL mouse is a rare exception, able to fully close ear hole punctures 
with the formation of a highly-proliferative cell population known as a blastema. MRL mice do 
not express the cell cycle regulator p21, and when the p21 gene is ablated in wild-type mice, they 
too acquire the ability to regenerate lost ear tissue. This p21 knockout mouse demonstrated that a 
lack of p21 confers regenerative abilities in an otherwise regeneration-incompetent species. The 
transition from G1 to the S-phase of the cell cycle is regulated by p21 binding to cyclin and CDK 
complexes, preventing continuation of the cycle until any detected DNA damage is repaired. A 
p21 gene has not been identified in the newt; however, a CDK inhibitor with sequence similarity 
to human p21 was found in the closely related axolotl, Ambystoma mexicanum. Using this partial 
axolotl sequence to design primers, qPCR analysis revealed that expression of a p21-like gene 
was down-regulated at 14 and 21 dpa. A series of Western blots were performed in order to find 
a suitable antibody that cross-reacted with newt p21. Unfortunately, p21 protein was not detected 
in any tested newt sample suggesting that either the antibodies used were unable to recognize 
p21 in the newt, p21 is expressed at very low levels in the newt, or the newt completely lacks 
p21 protein expression. During these studies, a cell cycle related protein, CDKN2A interacting 
protein N-terminal like, or p16 interacting protein, was detected in both regenerating and 
unamputated newt tail tissue with changes in expression over the course of regeneration. Similar 
to p21, p16 is a CDK inhibitor that specifically targets Cyclin D and CDK4/6 to inhibit cell cycle 
progression, but previous research has been unable to identify this gene in regenerators such as 
the newt and axolotl. Overall, this work represents the first exploration of p21 expression and the 
first evidence of p16-related proteins in the regeneration-competent newt. 
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Introduction 
 
 The Murphy Roths Large mouse is capable of epimorphic regeneration in ear tissue 
injured by identification hole punctures (Clark et al., 1998). Further examination has determined 
that these mice can regenerate damaged heart and brain tissue as well (Hampton et al., 2004; 
Heber-Katz et al., 2004; Leferovich and Heber-Katz, 2002; Leferovich et al., 2001). 
Understanding why this otherwise regeneration-incompetent species possesses this ability is 
paramount in establishing the factors required for successful regeneration. Similarly, the 
continued study of how regeneration-competent species, such as the newt, are capable of 
replacing lost limbs and organs is vital to determine the elements necessary for this process. 
Together, this information can help define the features essential for regeneration and the 
molecular differences that exist between regeneration-incompetent and regeneration-competent 
organisms. 
 It was established by Bedelbaeva et al (2010) that a lack of p21 protein expression in the 
MRL mouse was linked to the ability to regenerate. Subsequent p21 knockout experiments, 
performed by the same research group, demonstrated that the abolishment of p21 expression in 
an otherwise normal mouse conferred the same regenerative capabilities (Bedelbaeva et al., 
2010). Given that a lack of p21 conferred regenerative abilities in mice, which are typically 
considered regeneration-incompetent animals, it is of interest to understand the role that p21 
plays in the regeneration-competent newt species, Notophthalmus viridescens. Would a lack of 
p21 also be found in this species, potentially highlighting the importance of this cell cycle 
regulator to regeneration in a variety of organisms? Or, if p21 protein is expressed in the newt, 
why would the lack of p21 confer regenerative abilities in these mice? To provide insight into 
these questions, I first examined the temporal expression patterns of both p21 mRNA and protein 
during caudal tail and spinal cord regeneration in the newt. mRNA transcript expression of p21 
was not originally studied in the MRL mouse, so it is of interest to determine if p21 gene 
expression varies between intact and amputated tails. As well, I wanted to account for potential 
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issues in detecting p21 protein expression in the newt since in a previous study by Dolezalova et 
al (2012) looking at p21 expression in human embryonic stem cells (hESCs), changes were 
found in p21 RNA expression, but p21 protein was not detected whatsoever. p21 mRNA was up-
regulated after the DNA damage response was triggered in hESCs, but no subsequent increase in 
p21 protein expression was observed (Dolezalova et al., 2012). If a lack of p21 is involved in the 
newt’s ability to regenerate caudal tail and spinal cord tissue, then it is expected that there will be 
low to virtually undetectable p21 transcript and protein expression across unamputated and 
regenerate time points, as in the MRL mouse. Given that the MRL mouse exhibits a mechanism 
of regeneration very similar to that of the newt, it is predicted that p21 expression will be 
minimal in basal and regenerating tail. 
 The regenerating caudal tail and spinal cord of the newt were chosen for this 
investigation as the tail tissue undergoes epimorphic regeneration; characteristics of which are 
observed in the MRL mouse’s regenerative process, making it an ideal comparison tissue. 
Furthermore, the regenerating spinal cord is unique to the adult newt and offers the greatest 
potential for future medical applications, highlighting the importance of establishing the role of 
p21 in this process. Time points of 7, 14, and 21 days post tail amputation were examined for 
both p21 gene and protein expression studies as these time points define three distinct stages of 
tail regeneration, representing significant morphological changes in the regenerating tail (Iten 
and Bryant, 1976). At seven days post amputation, blastemal cells are first seen accumulating 
below the thickened wound epidermis, and the terminal vesicle of the ependymal tube appears 
caudal to the amputation plane (Iten and Bryant, 1976). Several mitotic figures are present along 
the ependymal tube, confirming active cell cycling within the regenerate at this time (Iten and 
Bryant, 1976). By fourteen days after amputation, the process of chondrogenesis is apparent as a 
cartilaginous rod, which provides a scaffold for the regenerating spinal cord, develops within the 
narrowed and elongated blastema (Iten and Bryant, 1976). Twenty-one days post amputation, the 
regenerating tail is undergoing extensive differentiation of a variety of tissue types and the final 
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stages of morphogenesis occur (Iten and Bryant, 1976). In addition to these hallmark stages of 
regeneration, changes in gene expression triggered by injury can be transient events, underlining 
the need for an examination of earlier time points at 1, 2, and 3 days post amputation as well. 
This phenomenon was previously illustrated when studying the expression of p21 in response to 
induced mouse liver damage (Fan et al., 2014). Upon administration of damage-inducing 
concentrations of acetaminophen, p21 was only shown to be up-regulated at 24 hours post 
exposure, immediately returning to nearly undetectable basal levels by 48 hours post injection, 
demonstrating that changes in p21 expression have the potential to be very brief events (Fan et 
al., 2014).  
 Examination of mRNA transcripts determined that expression of a p21-like gene changes 
over the course of regeneration. Extensive Western blotting analysis determined that none of the 
commercially available anti-p21 antibodies tested were able to detect p21 protein in unamputated 
or regenerating newt tail samples. A peptide sequence matching a p16 interacting protein, which 
associates with the p21-related CDK inhibitor p16, was detected in newt tissues. These findings 
represent the first look at mRNA and protein expression of p21 in the regenerating newt, and 
indirectly suggest a role for the related cell cycle regulator, p16, in this regenerative process.  
Materials & Methods 
 
Animal Care and Surgery 
 
 All handling and surgical procedures were approved by the Brock University Animal 
Care and Use Committee (Protocol #13-05-01). Adult Eastern red-spotted newts, Notophthalmus 
viridescens, were obtained from Boreal Northwest in St. Catharines, Ontario and were utilized in 
all experiments. Animals were housed in plastic containers with dechlorinated water for the 
duration of experiments. Water changes occurred after every liver feeding, 3 days per week. 
Prior to each surgery, newts were anesthetized by bathing in a 0.1% solution of m-aminobenzoic 
acid ethyl ester methane sulfonate (pH=7.0, MS-222, Sigma). Tail amputations were performed 
caudal to the cloaca, ensuring that any incisions made on previously amputated animals were 
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made rostral to prior tail amputations. Studies have shown that repeated rounds of regeneration 
lead to no adverse effects on tissue architecture, gene expression, and regenerative capacity 
(Eguchi et al., 2011). The tail tissue removed during the initial amputation surgery represents the 
unamputated (day 0) tail tissue sample. Tail blastema tissue recovery involved a second 
amputation a few millimeters rostral to the original wound plane, with focus on obtaining 
regenerated tissue primarily. Newts recovered on ice for approximately ten minutes post surgery, 
and then were placed on a damp paper towel to fully recover before being re-immersed in water. 
Xenopus, zebrafish, and rat tissues were obtained from euthanized animals used in other research 
protocols and all tissue was taken post-mortem. 
Reverse Transcription – Quantitative Polymerase Chain Reaction (RT-qPCR) Analysis 
 
 Newt tail tissues were collected following amputation and immediately placed in liquid 
nitrogen to be stored as individual samples at -80°C until needed. RNA isolation was performed 
using the Norgen Biotek Animal Tissue RNA Purification Kit and the NanoVue Plus 
spectrophotometer (General Electric) was used to assess the 260/280 nm absorbance ratios and 
RNA concentrations.  Only those samples with 260/280 ratios greater than 1.8 and 
concentrations above 100ng/µL were utilized. Synthesis of cDNA required 500ng of each RNA 
sample and was performed with the BioRad iScript cDNA Synthesis Kit. In accordance with the 
Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) 
guidelines, 3 biological and 3 technical replicates were run following primer validation using 
standard curves (Taylor et al., 2009). An additional 4 biological replicates of newt tail tissue 
were added to the study for each time point, increasing the overall sample size to 7. Real-time 
qPCR was performed using the BioRad CFX Connect Real-Time detection system using BioRad 
SsoAdvanced SYBR Green Supermix for the detection of amplified DNA. Data were analyzed 
using the ΔΔCT method (BioRad CFX Manager program) normalizing all samples from the target 
p21 to the reference genes alpha tubulin and caspase 3, and then reporting expression relative to 
the calibrator of unamputated (Day 0) control tail. PCR product was sent to Nanuq – McGill 
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University and Genome Quebec Innovation Centre for sequencing to confirm identity. Primers 
were designed using Primer3 and can be found in Table 2.1. 
Table 2.1: Primer Sequences for Reverse Transcription-Quantitative Polymerase Chain 
Reaction Analysis 
Primer Name Primer Sequence (5’ to 3’) 
Alpha Tubulin Forward ACTGGAGTCAGGTGGACGAC 
Alpha Tubulin Reverse ATTGAGGGTTGCCTTCAGTG 
Caspase 3 Forward CAACAGGACCACAGCAAAAG 
Caspase 3 Reverse AATCTCCTCCACTGTCTGCC 
p21 Forward ATAGGACAGTGTGGGTGAGC 
p21 Reverse CTTAATACGTGTGTGGGCGG 
 
Western Blot Analysis 
 Newt tail tissues were obtained under the same procedure as for RT-qPCR analysis and 
stored as individual samples at -80 ° C until needed. Protein isolation involved homogenizing 
individual tissue samples in lysis buffer for 30 seconds, followed by 30 minutes of centrifugation 
to pellet cellular debris. Supernatant was collected and analyzed using the Pierce BCA protein 
assay kit to determine protein concentration. Equal amounts (µg) of total protein from each 
sample were used after combination with a Laemmli protein loading dye.  Samples were loaded 
onto 12% resolving and 4% stacking polyacrylamide gels along with protein molecular weight 
standards (Thermo Scientific PageRuler Prestained NIR Protein Ladder) and run for 2-3 hours at 
80V.  Gels were then transferred to Polyvinylidene fluoride (PVDF) membranes (Millipore) at 
100V and below 0.35A for 60 minutes.  
 In separate trials, blots were then incubated overnight with shaking at 4 °C, with each 
primary antibody following 1 hour shaking in blocking buffer (1xPBS/3% Milk powder/0.1% 
Tween 20 or 1xPBS/5% BSA/0.1% Tween 20). Primary anti-p21 antibodies used included: 
Abcam anti-p21 rabbit polyclonal antibody (ab7960), Acris rabbit anti-human CDKN1A/p21 
WAF1 p21 Antibody (AP06263PU-N), Sigma monoclonal anti-p21Waf1/Cip1 mouse antibody 
(P1484), and Cell Signaling Technology p21 Waf1/Cip1 (12D1) Rabbit mAb (2947). Control 
primary antibodies used were an Abcam anti-beta actin antibody (ab8227) and a Developmental 
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Studies Hybridoma Bank (DSHB) anti-alpha tubulin antibody (AA4.3 was deposited to the 
DSHB by Walsh, C. (DSHB Hybridoma Product AA4.3)). Additional antibodies utilized: DSHB 
anti-Drosophila melanogaster p53 antibody (Dmp53 H3 was deposited to the DSHB by 
Ollmann, M. (DSHB Hybridoma Product Dmp53 H3)), DSHB anti-Cip1-interacting zinc finger 
protein antibody (PCRP-CIZ1-1A2 was deposited to the DSHB by Protein Capture Reagents 
Program, produced by JHU/CDI (DSHB Hybridoma Product PCRP-CIZ1-1A2)), Abcam Anti-
active + pro Caspase 3 antibody (ab13847), Cell Signaling Technology (CST) total ERK p44/42 
MAPK (4696) and Phospho ERK p44/42-Thr202/Tyr204 (4370), and CST anti-Caspase 3 
antibody. Following washes, blots were incubated for 45 minutes with either the Alexa Fluor 680 
goat anti-rabbit or goat anti-mouse secondary antibody in a 1:15000 dilution of blocking 
solution. Blots underwent a final 1xPBS wash and were stored with 1xPBS at 4°C protected 
from direct light until visualization using the Odyssey Infrared Imaging system at 700 nm.  
 HeLa human epithelial carcinoma cell line whole cell lysate, used as a control sample for 
the p21 antibodies, was obtained from Abcam (ab150035). Mouse C2C12 muscle cell lysate 
protein, SHSY5Y neuroblastoma cell lysate protein, and rat hippocampus protein samples were 
donated from labs of Drs. Stuart and McCormick. Various Xenopus, rat, and zebrafish tissues 
were obtained from euthanized animals post-mortem.  
 In order to assess each primary anti-p21 antibody’s ability to recognize p21 protein in 
newt tissue, a number of parameters were altered including: protein concentration, antibody 
concentration, gel percentage, imager used, blocking solution, and secondary antibody utilized. 
Protein sequencing and identification was carried out by Harvard University’s Mass 
Spectrometry and Proteomics Resource Lab. 
Protein Identification Analysis of the detected low molecular weight band 
 Unamputated (day 0) tail protein sample was run on a 12% resolving and 4% stacking 
polyacrylamide gel along with protein molecular weight standards (Thermo Scientific PageRuler 
Prestained NIR Protein Ladder) for 30 minutes at 80V until the samples reached the interface of 
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the stacking and resolving gels, followed by 3 hours at 100V. From this point on sterility was of 
the utmost importance to minimize skin-derived keratin contamination of the protein sample. 
The gel was stained with Coomassie Brilliant Blue R250 overnight, with 3 solution changes. The 
next morning the gel was incubated with destain solution two times for 30 minutes each in order 
to remove the dye without disturbing the sample. Careful excision and isolation of the target 
band was performed, placing the sample in a sterile 1.5mL eppendorf tube. At this point the 
sample was shipped on dry ice for Protein Identification Analysis to Harvard’s Mass 
Spectrometry and Proteomics Resource Lab. The data obtained from the analysis were provided 
as a detailed excel file indicating the peptide fragments detected in the low molecular weight 
band. Upon further analysis using the National Center for Biotechnology Information’s (NCBI) 
Basic Local Alignment Search Tool (BLAST), 418 unique peptide fragments were identified 
from the protein sequence data. 
Custom Peptide Synthesis and Analysis 
 Using sequence information for the Human p21 epitope, the Xenopus p16 interacting 
protein, and the Xenopus p16 protein (that is homologous to human p21), three custom peptides 
were designed and sent to ThermoFisher Scientific for synthesis (Table 2.2). Upon arrival,  
Table 2.2: Amino acid sequences for three custom peptides designed to test the Sigma anti-
p21 antibody. 
 
lyophilized peptides were centrifuged and reconstituted with sterile water to achieve a final 
concentration of 1ug/mL. First, PVDF membranes were activated in methanol and saturated in  
1xPBS/0.1% Tween 20 in order to run a series of dot blots. A grid was created on each 
membrane to separate and distinguish the tested samples. Various concentrations of each peptide 
were applied to the membrane in tight droplets with dye-free unamputated (day 0) tail protein 
Peptide name Amino acid sequence 
Human p21 epitope ALMAGCIQEARERW 
Xenopus p16 interacting protein MAEGIVVEDAPHFTTR 
Xenopus p16 EFMQKSNEEAKAKW 
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being used as a control sample. After all samples were absorbed into the PVDF membrane, the 
dot blot was blocked for one hour in 1xPBS/3% BSA/0.1% Tween 20 solution followed by 
overnight incubation with the primary Sigma anti-p21 antibody in the same solution. The next 
morning, the dot blot was washed with 1xPBS/0.1% Tween 20 and then incubated for 45 
minutes with the Alexa Fluor 680 goat anti-mouse antibody in blocking solution. Blots 
underwent a final 1xPBS wash and were visualized using the Odyssey Infrared Imaging system 
at 700 nm.  
 The Western blotting protocol for testing the peptides followed those steps described 
above with a few distinct differences: first, the gel was only run for 1 hour at 80V to prevent the 
peptides from running off the gel as they were much smaller than denatured protein samples; 
second, the peptides were mixed with normal protein loading dye instead of Laemmli in order to 
maximize the amount of peptide sample (in micrograms) that could be loaded on the gel; and 
third, a 15% resolving gel was used rather than a 12% gel to increase the resolution of the 
peptides given their low molecular weight.  
Statistical Analysis 
 A one-way ANOVA was performed using GraphPad Prism 6 to examine temporal 
expression differences in mean p21 gene expression, normalized to alpha tubulin and caspase 3 
expression and reported relative to time zero (ΔΔCT method). A post-hoc Tukey test was run for 
each ANOVA. A p-value less than 0.05 was considered significant.  
 Densitometric analysis was performed on Western blots using ImageJ software, however 
normalized mean band density could not be determined using statistical analysis due to the 
inconsistency of the anti-beta actin antibody in unamputated and regenerating newt tissues. 
Instead, the raw, unnormalized density values calculated using ImageJ were compared using a 
one-way ANOVA in GraphPad Prism 6 to simply indicate if visual band differences were 
associated with numerical differences in band density. A sample size of at least two blots was 
required for this analysis. A post-hoc Tukey test was run for each ANOVA. A p-value less than 
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0.05 was considered significant. 
Results 
Transcripts of a p21-like gene are down-regulated during regeneration 
 Reverse-transcription qPCR analysis was performed across the six regenerative time 
points of 1, 2, 3, 7, 14, and 21 dpa comparing relative expression to unamputated (day 0) control 
tissue. A newt-specific p21 sequence is not available in the literature, so primers were designed 
from the closely-related regeneration-competent axolotl, Ambystoma mexicanum, partial contig 
sequence that shares approximately 44% identity with Human p21 (Heber-Katz et al., 2012). The 
CDK binding domain is the site of greatest similarity between these two sequences, making it the 
ideal location at which to design primers. Figure 2.1 depicts the results of the RT-qPCR analysis, 
showing the expression of the newt p21-like gene relative to the two housekeeping genes alpha-
tubulin and caspase-3 (N=7, F(6,42)=6.935, p < 0.0001). A significant down-regulation of p21 
transcripts relative to day 0 is seen at both 14 and 21 days post amputation (post-hoc Tukey test 
p<0.05 and p<0.01, respectively). There appears to be a gradual decline in p21 mRNA across 
regeneration stages, although statistical significance relative to unamputated tissue is only seen at 
14 and 21 days. Additionally, post hoc analysis revealed a significant down-regulation of p21 
expression between day 1 and days 7, 14, and 21 regenerates, and a statistically significant 
difference between day 2 and day 21 regenerates. In order to confirm the identity of the 
amplified sequence as p21, qPCR products were run on a gel and sent to Nanuq – McGill 
University and Genome Quebec Innovation Centre for sequencing. Figure 2.2 depicts the 
sequence alignment of 46.8% identity and similarity between the p21 qPCR product and the 
axolotl p21 contig. Nucleotides 96 to 112 match the complementary sequence to the reverse 
primer designed from the axolotl contig for the qPCR reaction, suggesting that the amplified 
product contains a series of bases that are identical to the axolotl p21 sequence. The predicted 
184 base pair newt product encompassed the axolotl CDK binding domain that, as mentioned 
above, is the region of p21 sequence that shares the greatest similarity with human and other 
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known p21 sequences such as Xenopus (Heber-Katz et al., 2012). This is a fairly short sequence 
for comparison, and when excluding the sequence that is identical to the reverse primer (which  
!  Figure 2.2: Validating that the amplified qPCR product is p21. Sequence alignment 
shows 46.8% identity and similarity of the qPCR product (newtp21pcrpro) with the 
Ambystoma mexicanum (Axolotlp21con) p21 contig. The sequence present from nucleotides 
96 to 112 of the newt sequence matches the complement of the reverse primer. 
 
 
Figure 2.1: Expression of a p21-like gene is down-regulated at 14 and 21 days post tail 
amputation. Relative normalized expression of p21-like mRNA transcripts to the two 
reference genes Alpha Tubulin and Caspase-3. Day 0 (unamputated) tissue is used as the 
calibrator control (N=7, F(6,42)=6.935, p < 0.0001; * p<0.05, ** p<0.01 compared to Day 0). 
p21 expression at days 7, 14, and 21 all differ significantly from day 1 regenerate tissue (#; 
p<0.05, p<0.01, and p<0.001, respectively). Day 21 is significantly down-regulated when 
compared to day 2 tail regenerate samples ($; p<0.01). 
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would be amplified in subsequent rounds of the qPCR reaction) minimal newt-specific sequence 
remains that matches the axolotl p21 sequence. This qPCR data represents the most complete 
newt sequence obtained from a p21-like gene, but the data is insufficient to conclude newt-
specific p21 has been amplified, stressing the need for more extensive study of the newt genome.   
All commercially available p21 antibodies fail to recognize newt p21 protein  
 To begin the process of identifying p21 protein in the newt, an anti-p21 antibody from 
Acris was chosen as the first commercial antibody because it was raised in rabbit, showed 
specificity for human, rat, and mouse, and its epitope was predicted to bind to the CDK binding 
domain of human p21 - the region of greatest sequence similarity to the known axolotl contig. 
Samples from the mouse C2C12 muscle cell line, HeLa cervical carcinoma cell line, and pooled 
rat hippocampus brain tissue were run alongside unamputated (day 0) newt tail tissue on a 
Western blot (Figure 2.3). Using 40ug of newt tail and all other protein samples, a band was not 
detected at the expected molecular weight of 21 kDa with either 1/500 or 1/1000 primary anti-
p21 antibody dilutions. There was, however, a single band detected for only the newt tail sample 
at each dilution used that measured between 10 and 15 kDa. Continued testing of this antibody 
was unable to identify p21 protein in any of the tested samples at 21 kDa. Notably, the product 
information for this Acris p21 antibody indicated that in a HeLa cell extract sample, a single 
band was recognized below 25 kDa at approximately 21 kDa, but I was unable to detect p21 
protein in the HeLa cell sample I tested with this same antibody.  
 An anti-p21 antibody from Abcam was tested next because it was shown to cross react in 
human, mouse, and rat tissues, with a consistent band detected at approximately 18-20 kDa 
indicating p21 expression. Figure 2.4 is a representative Western blot of mouse C2C12 muscle 
cell lysate, HeLa cells, rat hippocampus brain tissue, and unamputated tail tissue probed with this 
anti-p21 antibody. After repeatedly testing this antibody by changing a number of variables such 
as the amount of protein loaded, the primary antibody dilution, and the gel percentage, it was 
decided that the Abcam anti-p21 antibody failed to recognize p21 protein in any of the tested  
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Figure 2.3: Representative Western blot image of various mammalian and newt tissue 
samples probed with the Acris anti-p21 antibody. A) The Acris anti-p21 antibody used at a 
1/500 dilution and B) The Acris anti-p21 antibody used at a 1/1000 dilution. Protein from 
various tissues are as follows: rat hippocampus, mouse C2C12 muscle cell lysate, HeLa cells, 
and unamputated (day zero) newt tail tissue. The arrow on the right highlights a low 
molecular weight band detected at approximately 14 kDa in only the unamputated newt tail 
samples at both tested antibody dilutions. 
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Figure 2.4: Representative Western blot image of various mammalian and newt tissue 
samples probed with the Abcam anti-p21 antibody and anti-beta actin control.        
A) The Abcam anti-beta actin control antibody used at a 1/500 dilution and B) The Abcam 
anti-p21 antibody used at a 1/500 dilution. Protein from various tissues are as follows: rat 
hippocampus, mouse C2C12 muscle cell lysate, HeLa cells, and unamputated (day zero) newt 
tail tissue. The arrow at the middle highlights actin expression in lanes 1, 2, and 3 at 
approximately 40 kDa. The faint band that suggests a lack of beta actin expression in the time 
zero newt sample was a common observation with unamputated newt tails, which were 
always less than regenerate newt tail samples. 
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newt and mammalian samples, making it an unusable antibody for this study. It is worth noting 
that this antibody has since been discontinued from Abcam’s product line and is no longer 
available for purchase. 
 A mouse monoclonal anti-p21 antibody from Sigma was chosen as the next antibody to 
test as the epitope is located at amino acids 17-30 of the CDK binding domain of human p21.  
The CDK binding region represents the most highly conserved portion of the p21 amino acid 
sequence between common model organisms like the mouse, rat, and Xenopus (Heber-Katz et 
al., 2012). As with the two previous antibodies, a variety of antibody and protein concentrations 
with different mammalian and tail regenerate protein samples at various time points were tested.  
 Upon first use of the Sigma anti-p21 antibody, it was clear that it recognized a low 
molecular weight protein of approximately 14/15 kDa, only in newt samples, that demonstrated 
temporal changes in expression (Figure 2.5). The protein recognized by the p21 antibody was 
highly expressed at day 0 with downregulation seen at 7 and 14 dpa followed by an increase at 
21 dpa (see appendix for quantification, NDay0=8 and N=5). As with the previous two antibodies, 
the mouse C2C12 muscle cells, HeLa cell lysate, and rat hippocampus brain samples did not 
show expression of p21 at the expected weight of 21 kDa. The lack of a band at 21 kDa in any of 
the tested mammalian samples was concerning, but the low molecular band in the newt samples 
represented an intriguing possibility of a unique p21-like protein in the newt that could be 
differentially expressed during regeneration. As well, a protein with similar molecular weight 
was initially detected in unamputated newt tail tissue with the Acris anti-p21 antibody, further 
supporting the notion that this band could represent a p21-related newt protein.  
 Before continuing with this antibody for the purposes of establishing p21 expression in 
the newt, it was essential to verify that the antibody is accurately recognizing the appropriate 
antigen by finding a reliable positive control protein sample. In the adult mouse, p21 is typically 
restricted to terminally differentiating cells like those in the heart, lungs, and brain, with the 
greatest expression seen in tissues with high turnover cell populations such as the linings of  
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Figure 2.5: Representative Western blot image of various mammalian and newt tissue 
samples probed with the Sigma anti-p21 antibody and later reprobed with the Abcam 
anti-beta actin control antibody. The anti-p21 antibody used at a concentration of 5 ug/mL. 
The anti-beta actin antibody used at a 1/500 dilution. Protein from various tissues are as 
follows: HeLa cells, mouse C2C12 muscle cell lysate, rat hippocampus, two biological 
replicates of unamputated (day zero) newt tail tissue, day 7 regenerate newt tail tissue, day 14 
regenerate newt tail tissue, and day 21 regenerate newt tail tissue. The orange arrow on the 
right highlights a low molecular weight band recognized by the Sigma anti-p21 antibody at 
14/15 kDa in only newt tissue at all stages of regeneration in the tail. The blue arrow on the 
right indicates beta actin expression in each of the tested tissues. 
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intestinal walls (Bouvard et al., 2000; Gartel and Tyner, 2002; Macleod et al., 1995). With access 
to euthanized rat and Xenopus specimens, a variety of tissue types were collected for the purpose 
of testing these antibodies. Xenopus lung, rat liver, and human buccal cells were tested alongside 
newt tail regenerate time points with the Sigma Anti-p21 antibody in an attempt to find a suitable 
positive control (Figure 2.6). Once again, the p21 antibody recognized a low molecular weight 
band of approximately 15 kDa in the regenerating newt tail tissue. As well, smeared bands were 
detected at slightly above 25 kDa in newt tail tissue, as they were in Figure 2.5, with visible 
changes in expression over time that parallel those in the smaller band around 15 kDa. 
Interestingly, continued use of the antibody solution on additional blots resulted in a gradual 
disappearance of these smears, without changes to the signal strength in the low molecular 
weight band, suggesting that the smears were related to initial non-specific binding of the 
antibody to proteins in the newt tissue. 
 Unfortunately, none of the newly tested human, rat, and Xenopus tissues exhibited p21 
expression at the expected molecular weight of 21 kDa, removing them as options for potential 
control mammalian or amphibian samples to use with the Sigma p21 antibody. The consistent 
expression of a band at approximately 35 kDa in both rat hippocampus (Figure 2.5) and rat liver 
(Figure 2.6) samples were similar to the band observed in the PC12 (rat adrenal medulla 
pheochromocytoma) cell lysate sample included in the Sigma p21 antibody product information.  
 It should be noted that in continued testing of this antibody (which included nearly 20 
additional blots, some of which can be found in the appendix), the Western blot loading control 
was eventually switched from beta actin (Abcam) to alpha tubulin (DSHB) as it was more 
consistently expressed over the course of regeneration. Beta actin was typically expressed at very 
low levels at day zero and would exhibit increased expression in response to amputation, making 
it an unreliable control from which to normalize protein expression (Figures 2.5 and 2.6). Alpha 
tubulin, on the other hand, was consistently expressed at relatively the same density in 
unamputated and regenerating newt tail samples, making it an ideal control sample (Figure 2.7).  
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Figure 2.6: Representative Western blot image of additional mammalian and newt tissue 
samples probed with the Sigma anti-p21 antibody. A) The anti-p21 antibody used at a 
concentration of 5 ug/mL. B) The anti-beta actin antibody used at a 1/500 dilution. Protein 
from various tissues are as follows: human buccal cell lysate, rat liver tissue, Xenopus lung 
tissue, two biological replicates of unamputated (day zero) newt tail tissue, day 7 regenerate 
newt tail tissue, day 14 regenerate newt tail tissue, and day 21 regenerate newt tail tissue. The 
arrow on the right highlights a low molecular weight band recognized by the Sigma anti-p21 
antibody at 14/15 kDa in only newt tissue at all stages of regeneration in the tail.  
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Figure 2.7: Alpha Tubulin is consistently expressed during newt regeneration. Western 
blot probed with the Cell Signaling Technology anti-alpha tubulin antibody demonstrating 
consistent tubulin expression in newt tail tissues at 55 kDa. Protein from various tissues are as 
follows: unamputated (day zero) tail tissue, day 7 regenerate tail, day 14 regenerate tail, and 
day 21 regenerating tail. 
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 To further examine this putative newt protein, and determine if it is solely expressed in 
newt tail tissue, protein from unamputated and regenerating newt limbs was also tested (Figure 
2.8). Comparable to the tail, the Sigma anti-p21 antibody recognized a low molecular weight 
protein in unamputated and regenerating newt limbs. This protein also demonstrated temporal 
changes in abundance (see appendix for quantification, N=2), suggesting that this p21-like 
protein may play a role in the regenerative response of both the tail and limb. The inability to 
find a suitable control sample and confirm that the antibody was accurately recognizing a p21-
like protein in the newt samples led to three separate lines of investigation: first, testing if the 
low molecular weight band represents a cleaved fragment of p21; second, isolating the low 
molecular weight band and submitting it for protein sequencing; and third, synthesizing the 
peptide epitope used to produce the antibody and directly testing its ability to bind to the 
antibody on a blot. 
 Previous studies by a number of research groups have shown that in the presence of 
active caspase-3, p21 may be cleaved into a smaller p14/p15 fragment (Chai et al., 2000; Gervais 
et al., 1998; Park et al., 1998; Zhang et al., 1999). Caspase-3 plays a major role in the cell’s 
apoptotic pathway. Originally present as an inactive proenzyme, cleavage of caspase-3 by 
caspases 8 and 9 activates the protein, allowing it to function in apoptosis as the ‘executioner’ 
(Connolly et al., 2014). The cleavage activity is concentration dependent in that the greater the 
expression of caspase-3, the more likely that p21 will be cleaved (Zhang et al., 1999). 
Bedelbaeva et al. (2010) demonstrated that caspase-3 is only expressed in the MRL mouse and 
not wild-type mice, suggesting the necessity of apoptosis to the regenerative process. 
Furthermore, caspase activity has been linked to both early Xenopus tail regeneration and 
forelimb regeneration in N. viridescens (Tseng et al., 2007; Vlaskalin et al., 2004). In order to 
indirectly test if cleavage by caspase-3 may be linked to the low molecular weight band present 
in newt tissue, two different caspase-3 antibodies that recognize both the proenzyme and active 
forms (at 32 and 15 kDa, respectively) were tested on a variety of tissues. The Cell Signaling  
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Figure 2.8: Representative Western blot image of newt limb samples probed with the 
Sigma anti-p21 antibody.  The anti-p21 antibody used at a concentration of 5 ug/mL. Protein 
from various tissues are as follows: unamputated (day zero) newt limb tissue, day 7 regenerate 
newt limb tissue, day 14 regenerate newt limb tissue, and day 21 regenerate newt limb tissue. 
The arrow on the right highlights a low molecular weight band recognized by the Sigma anti-
p21 antibody at 14/15 kDa in these limb tissue samples that mirrors the results seen with 
regeneration in the tail.  
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Technology anti-caspase-3 antibody recognized the proenzyme of caspase-3 in the tested HeLa 
cell and mouse C2C12 muscle cell samples, but none of the newt samples cross-reacted with the 
antibody.  
 A caspase-3 antibody from Abcam was then chosen after a series of in silico alignments 
predicted there was potential for the antibody to recognize caspase-3 in the newt. Original 
observations of these Western blots noted the location of bands in newt tail tissue at weights 
double or triple the expected 35 kDa weight of pro-caspase-3; however, upon review of an 
additional blot with increased exposure, it would appear that the proenzyme of caspase-3 is 
expressed between 24 and 32 kDa in day 7 regenerating tissue (Figure 2.9). A band at 
approximately 11 kDa can be seen in newt tail samples 0, 7, and 14 dpa, which is close to a small 
12 kDa fragment that can be created when caspase-3 is cleaved (Abcam product info), but it is 
unclear whether these bands represent active caspase-3. As expected, the expression of both pro-
caspase-3 and active caspase-3, at approximately 32 kDa and 15 kDa, respectively, can be seen 
in the rat hippocampus sample that was run as a control. Although this antibody was originally 
abandoned for use in Western blotting, recent immunofluorescence work in our lab has 
demonstrated extensive protein expression in day 7 regenerating newt tails utilizing this caspase-
3 antibody (Wlodarek, BSc. Honours Thesis), suggesting that it may be worth testing the 
antibody again in the future. In order to confirm that both the western blot and 
immunofluorescent signals are caspase-3 expression, a blocking procedure using the 
commercially available peptide could be performed. For the purposes of my project, the focus 
shifted from establishing caspase-3 expression during regeneration to instead determining the 
identity of the low molecular weight band detected in the newt samples. 
Low molecular weight band identified as related cell cycle protein 
 After carefully excising the low molecular weight band, the sample was sent to Harvard 
University’s Mass Spectrometry and Proteomics Resource Lab for Protein Identification 
Analysis. The band was found to contain 418 unique peptide sequences. Each sequence was  
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Figure 2.9: Representative Western blot image of rat hippocampus and newt tissue 
samples probed with the Abcam anti-caspase-3 antibody. A) The anti-caspase-3 antibody 
used at a 1/500 dilution. The blue and orange arrows denote large proteins recognized by the 
antibody that are 2-3 times greater than the expected molecular weight of procaspase-3 at 32 
kDa. B) The anti-alpha tubulin antibody used at a 1/500 dilution. Protein from various tissues 
are as follows: two biological replicates of unamputated (day zero) newt tail tissue, two 
biological replicates of day 7 regenerate newt tail tissue, two biological replicates of day 14 
regenerate newt tail tissue, and two biological replicates of day 21 regenerate newt tail tissue. 
C) The anti-caspase-3 antibody used at a 1/500 dilution and subjected to a higher exposure 
(+3) when imaging. Protein from various tissues are as follows: unamputated (day zero) newt 
tail tissue, newt tail tissue from days 7, 14, and 21 dpa, and rat hippocampus. The red arrow 
highlights the approximately 32 kDa band that most likely represents procaspase-3 expression 
in the rat brain sample with a faint band present at a similar weight in the 7 dpa newt tail 
tissue sample. The green arrow points to a roughly 15 kDa band that represents active 
caspase-3. Newt tail samples at days 0, 7, and 14 recognize a band at approximately 11 kDa. 
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analyzed by hand using NCBI BLAST and one sequence was identified as sharing similarity 
with CDKN2A interacting protein N-terminal like or p16 interacting protein. p16 is a cyclin 
dependent kinase inhibitor that belongs to the INK4a family of inhibitors and specifically targets 
cyclin D and CDK4/6 (Lukas et al., 1995; Ruas and Peters, 1998; Serrano, 1997). This result 
represented the only cell cycle related protein to be detected in the newt tail sample. Alignment 
analysis determined that the identified peptide is 87.5% identical and 93.8% similar to Xenopus 
(X. laevis) p16 interacting protein (Figure 2.10). Further comparison between the newt (N. 
viridescens) peptide sequence and p16 interacting protein sequences from mouse (M. musculus), 
human (H. sapiens), and zebrafish (D. rerio), which are all evolutionarily conserved, 
demonstrates the remarkable degree of sequence similarity (Figure 2.11). It is worth mentioning 
that the Xenopus p21 gene is called p16Xic2 and is the functional ortholog of Human p21 
(Daniels et al., 2004; Zhu et al., 2013). The findings of the protein identification analysis indicate 
the potential for this antibody to be recognizing p16 interacting protein, which appears to be 
differentially expressed during regeneration, rather than p21 in the newt. In order to continue 
using the Sigma p21 antibody to examine p21, or p16 interacting protein expression in the newt, 
it was essential to validate the antibody and ensure it accurately recognizes p21 protein in other 
samples.  
The Sigma p21 antibody is unable to be validated  
 
 The peptide for the human p21 epitope, encompassing amino acids 17-30 of the CDK 
binding domain, was unavailable for purchase commercially, prompting the design of a series of 
custom peptides. The first peptide was identical to the human p21 epitope for the Sigma p21 
antibody to specifically test the antibody’s ability to recognize the sequence for which it was 
designed. The second peptide was designed to the Xenopus p16 interacting protein. The 
orthologous relationship between Xenopus p16 and human p21 formed the basis for the third 
peptide, utilizing the Xenopus p16Xic2 sequence in order to determine if the Sigma p21 antibody 
was recognizing a p21-like protein in the newt with similarities to the Xenopus sequence.  
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Figure 2.10: Sequence alignment of Notophthalmus viridescens peptide and Xenopus 
laevis p16-interacting protein N-terminal like. Sequence alignment using EMBL-EBI 
EMBOSS Water Pairwise Sequence Alignment program. CDKN2A interacting protein N-
terminal like Xenopus sequence obtained from NCBI. (|) = positions with a single, fully 
conserved residue, (:) = conservation between groups of strongly similar properties, and (.) = 
conservation between groups of weakly similar properties. 
 
Figure 2.11: Sequence alignment of Notophthalmus viridescens peptide and various p16-
interacting protein N-terminal like sequences. Sequence alignment using EMBL-EBI 
MUSCLE Multiple Sequence Alignment program. CDKN2A interacting protein N-terminal 
like sequences for Homo sapiens, Mus musculus, Danio rerio, and Xenopus tropicalis were 
obtained from NCBI. (*) = positions with a single, fully conserved residue, (:) = conservation 
between groups of strongly similar properties, and (.) = conservation between groups of 
weakly similar properties.  
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 In order to test the custom peptides, a series of dot blots were performed in which the 
peptides, in 3 increasing concentrations, were pipetted onto a PVDF membrane in addition to 
control newt tail protein samples. After exposure to the Sigma p21 antibody overnight, only the 
newt tail samples showed a dot, likely representing the same protein recognized at the low 
molecular weight on a Western blot (Figure 2.12). A series of Western blots were then 
performed as an additional method to potentially identify antibody recognition of any of the 
custom peptides, particularly the one matching the antibody’s epitope. Despite efforts to alter the 
gel percentage, run time, and the concentration of peptide and antibody used, none of the 
Western blots were able to demonstrate positive recognition of any of the custom peptides when 
exposed to the Sigma p21 antibody. There is the possibility that the lack of a visible dot or band 
could be attributed to the differences in how the epitope interacts with the antibody on its own 
versus how it interacts with the antibody when part of a larger protein/peptide. However, this 
inability to directly validate the Sigma p21 antibody led first to the examination of cell cycle 
related proteins, and the continued search for a p21 antibody capable of recognizing p21 protein 
expression in the newt. 
Testing other cell cycle related proteins 
 
 The struggle to successfully and accurately detect p21 protein expression in the newt 
using a p21 antibody led to the decision to study a variety of p21 related proteins to indirectly 
explore p21 expression. The first protein studied was p53, the canonical activator of p21 
expression in response to DNA injury. In mammals, p53 is responsible for maintaining stability 
of the genome by regulating gene expression in response to detected DNA damage, leading to 
either cell cycle arrest, senescence, or cell death (Vousden, 2000; Yun et al., 2013). A p53 
antibody, Dmp53, derived from the Drosophila melanogaster p53 peptide sequence was utilized 
because Drosophila p53 is the structural and functional homolog of the human tumor suppressor, 
p53 (Ollmann et al., 2000). The role of p53 in axolotl limb regeneration has been studied, 
indicating that early down-regulation of p53 is associated with blastema formation and its  
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Figure 2.12: Dot blot image of three custom peptides and newt tissue samples probed 
with the Sigma anti-p21 antibody. A) 1, 2, and 3 represent application of 10uL, 5uL, and 
2uL, respectively, of the custom peptide designed to match the epitope for the Sigma anti-p21 
antibody named p21. B) 1, 2, and 3 represent application of 10uL, 5uL, and 2uL, respectively, 
of the custom peptide designed to match the Xenopus p16-interacting protein N-terminal like 
sequence named p16int. C) 1, 2, and 3 represent application of 10uL, 5uL, and 2uL, 
respectively, of the custom peptide designed to match the Xenopus p16Xic2 (human p21 
ortholog) sequence named Xp16. D) Newt day 0 (unamputated) tail protein sample with 1 and 
2 each representing individual biological samples. E1) 20uL of the custom peptide designed 
to match the epitope for the Sigma anti-p21 antibody named p21. Dashed circles indicate 
areas of application to the PVDF membrane. Only the unamputated tail tissue samples show 
reactivity to the anti-p21 antibody.  
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subsequent up-regulation is required for later redifferentiation of the limb (Yun et al., 2013). It is 
key to note that in the study by Yun et al (2013), a custom axolotl p53 antibody raised against the 
peptide was used to examine the expression of p53. After testing unamputated and regenerating 
newt tail samples, there was no recognition of p53 expression with the Dmp53 antibody 
suggesting that a newt-specific antibody may be required to study p53 expression in the newt. 
 The next protein examined was Cip1-interacting zinc finger protein, or CIZ-1, which has 
been shown to interact with the p21 protein in human tissues (Copeland et al., 2010; Coverley et 
al., 2005; Mitsui et al., 1999; Nishibe et al., 2013). CIZ1 can induce cytoplasmic distribution of 
p21, and although no similar structure is found in yeast, C. elegans, or Drosophila, the presence 
of CIZ1 in humans and the Japanese pufferfish, Fugu rubripes, suggests conservation in 
vertebrates (Mitsui et al., 1999). It was uncertain if this antibody would cross-react in the newt, 
especially given our previous difficulties in detecting p21 expression, but it was worth testing 
this antibody in the event we could detect the interacting protein. Following similar testing as the 
Dmp53 antibody, there was no expression of CIZ-1 protein detected in any of the unamputated 
or regenerating newt tail samples.  
 The final p21 related proteins studied were extracellular signal-regulated kinase (ERK) 
and phosphorylated or phospho-extracellular signal-regulated kinase (p-ERK), which are 
involved in the control of cell proliferation in response to mitogenic signals. It has previously 
been shown that sustained ERK activation, indicated by p-ERK expression, is required for the 
cell cycle re-entry of postmitotic newt A1 myotubes, in part by down-regulating p53 expression 
(Yun et al., 2014). Continuous activation of ERK also causes the down-regulation of 
antiproliferative genes during the course of the G1 phase, contributing to cell cycle progression 
and entry into S phase (Yamamoto et al., 2006). A sample of rat hippocampus tissue was run 
alongside newt tail tissue and showed the expected two bands of total ERK protein expression, 
which includes ERK1 and ERK2, at 44 and 42 kDa, respectively. Total ERK1/2 protein 
expression was detected in unamputated newt tail and regenerate tail samples at 7, 14, and 21 
 52 
days after amputation (Figure 2.13A) as one band at approximately 43 kDa. The presence of a 
single band in the newt samples could be explained by the previous observation that Xenopus 
only possesses one ERK that is orthologous to human ERK2 (Lefloch et al., 2008; Lefloch et al., 
2009). Both ERK1 and ERK2 are present in fish such as Danio rerio, suggesting that erk1 has 
been lost in vertebrates like Xenopus and the chicken, Gallus gallus, as fish are evolutionarily 
closer to the common ancestor vertebrates (Lefloch et al., 2008). However, when newt A1 
myotube extracts were incubated by Yun et al. (2014) with an ERK antibody two bands were 
detected, with the 44 kDa band showing greater abundance. This finding in newt A1 myotubes 
could also illustrate the differences in determining ERK protein expression in a homogeneous 
cell culture versus the heterogeneous cell populations of the unamputated and regenerating newt 
tails.  
 When incubating the same samples with the pERK antibody overnight, only the rat brain 
sample showed cross-reactivity with the antibody, indicating activated ERK (Figure 2.13B). As 
it has been previously demonstrated that activated ERK is directly involved in the ability of newt 
myotubes to re-enter the cell cycle in vitro, it is possible that this phosphorylation leading to 
activation occurs on different amino acids in the newt than those recognized by this antibody 
(Yun et al., 2014). A further consideration for the lack of a phosphorylated ERK signal is that the 
lysis buffer used to process the newt protein samples did not include phosphatase inhibitors, 
leaving the phosphate groups susceptible to cleavage or degradation during tissue processing. Of 
these four p21-related proteins tested, extracellular signal-regulated kinase represents the most 
promising result with two blots showing no difference in expression across regenerated and 
unamputated tail tissues (see appendix for quantification, N=1 and N=2), suggesting its utility as 
a possible control antibody for Western blots in addition to alpha tubulin. At this point in time, 
these results provide little information regarding the role of p21 in the newt, but further 
exploration of activated ERK expression in vivo during tail regeneration could provide valuable 
information on cell cycle regulation and cell proliferation in this process.   
 53 
 
 
Figure 2.13: Representative Western blot image of mammalian and newt tissue samples 
probed with Cell Signaling Technology anti-ERK and anti-pERK antibodies. A) The 
anti-ERK antibody used at a dilution of 1/2000. B) The anti-pERK antibody used at a 1/1000 
dilution. Protein from various tissues are as follows: unamputated (day 0) newt tail tissue, day 
7 regenerate newt tail tissue, day 14 regenerate newt tail tissue, day 21 regenerating newt tail, 
and rat hippocampus. Only one band is seen in all tested newt tissues at approximately 42 kDa 
using the anti-ERK antibody, whereas the rat tissue shows the two expected bands for ERK1 
and ERK2 at 42 and 44 kDa, respectively. After probing with the anti-phosphoERK antibody 
(B), only the rat sample recognizes a single band at approximately 43 kDa. 
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Cell signaling technology p21 antibody recognizes positive control 
 
 After testing three p21 antibodies with little success in identifying p21 expression in newt 
tissue, or any mammalian samples, a final antibody from Cell Signaling Technology (CST) was 
tested. This specific p21 antibody was chosen given its prior success in Western blotting 
applications with a variety of cell types, a few of which were available for us to test together 
with newt tissue. Despite the antibody’s specific epitope sequence being unavailable, the 
antibody previously identified p21 in human and monkey samples, with expected reactivity in 
dog tissue (CST product information). The antibody was created using a synthetic peptide that 
corresponds to the carboxy-terminus of human p21. An alignment of a p21-like sequence from 
the Japanese newt, Hynobius retardatus, and the human p21 sequence was performed (37% 
identity and 51% similarity), indicating likeness at the carboxy-terminus and suggesting the 
potential for cross-reactivity in my newt, N. viridescens. The sequence from H. retardatus was 
found as an unidentified contig in the DNA database of Japan during the later stages of this 
project and I categorized it as a p21-like sequence given the high degree of similarity it shares 
with the human p21 protein sequence, specifically within the CDK-binding domain.  
 The first test of the CST p21 antibody involved utilizing a series of cell lysates from 
SHSY5Y cell cultures grown in media enriched with either glucose or galactose. SHSY5Y cells 
were selected because they were one of the cell types used successfully in the CST p21 antibody 
product information. They are human neuroblastoma cells and it has been shown that the 
sustained expression of p21 is required for the survival of differentiating SHSY5Y cells (Poluha 
et al., 1996). When testing the CST p21 antibody for the first time, four SHSY5Y samples (three 
cultured in galactose and one cultured in glucose) and two different day 0 newt tail samples were 
used (Figure 2.14). All four SHSY5Y samples recognized a band at approximately 21kDa 
representing p21, with a faint band at a lower molecular weight of approximately 15kDa. The 
CST p21 antibody failed to recognize protein in either of the newt tail samples. Five additional 
Western blots (see appendix for a few examples) were run, using differing antibody and sample  
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Figure 2.14: Representative Western blot image of human neuroblastoma (SHSY5Y) 
cells and newt tissue samples probed with the Cell Signaling Technology anti-p21 
antibody. A) The anti-p21 antibody used at a dilution of 1/500. B) The anti-alpha tubulin 
antibody used at a 1/500 dilution. Protein from various samples are as follows: SHSY5Y* cell 
lysates cultured with galactose, two biological replicates of unamputated (day zero) newt tail 
tissue, and SHSY5Y cell lysate cultured with glucose instead. The arrow on the right 
highlights p21 at approximately 20 kDa in all SHSY5Y cells tested. Neither of the newt 
samples tested recognize any proteins in response to being probed with the CST anti-p21 
antibody.  
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concentrations, and detection methods, with no success in detecting p21 protein expression in 
any newt tail sample. This inability to detect p21 protein in any of the tested regenerating newt 
tail samples led to the examination of p21 in a variety of other newt tissues, in addition to similar 
tissue types from other species.  
No newt tissues tested demonstrate reactivity with the CST anti-p21 antibody 
 The final attempt at Western blotting with the CST p21 antibody involved the use of 
tissues from the following four animals: newt, zebrafish, rat, and Xenopus. Newt tissues included 
both unamputated and pooled regenerating tail (from various time points), miR-1 and miR-133a 
mimic-injected tail, as well as brain, gut, and heart collected from newts that previously 
underwent tail amputation. Mimic-injected tail tissue samples are regenerate samples that were 
collected after microRNA mimics had been injected into the spinal cord, followed by 
electroporation. The microRNAs miR-1 and miR-133a have been previously shown in our lab to 
significantly inhibit newt tail regeneration (Lepp and Carlone, 2015). If the original hypothesis 
that a lack of p21 or very low basal expression contributes to the regenerative phenotype of 
newts is correct, then the use of mimic-injected tissue could help to determine if inhibiting the 
regeneration process alters the expression of p21 in the regenerating tail. Gut tissue from the 
newt was included in this analysis because previous research in our lab has shown the greatest 
expression of several proteins in the gut and this tissue’s cell population experiences a high 
turnover rate, which characteristically indicates the potential for prominent p21 expression. 
 Brain, spinal cord, and heart tissue were also used from zebrafish, rat, and Xenopus since 
they contain significant numbers of terminally differentiated cells and could express p21. The tail 
and fin tissues from the zebrafish were used such that the expression of p21 could be examined 
in two regeneration competent species simultaneously. Similarly, hindlimb tissue from Xenopus 
was run on the gel to represent a regeneration-competent species that undergoes a reduction in 
regenerative ability following metamorphosis. As a tadpole, Xenopus has what is considered 
unlimited regenerative potential, however after metamorphosis, this capacity diminishes, and in 
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the event of a hindlimb amputation, the missing limb is instead replaced by a hypomorphic 
cartilaginous rod or spike (Dent, 1962). Together, this collection of samples was chosen to 
represent a diversity of species and tissue types in order to provide the best chance of detecting 
p21 protein expression using the CST p21 antibody.  
 As can be seen in Figure 2.15A, of all the tested samples, only the SHSY5Y cell lysates 
recognized p21 protein at approximately 21 kDa. The corresponding alpha tubulin control for 
each sample, shown below in Figure 2.15B, indicated that all protein samples were intact and at 
a concentration suitable to at least be detected by the alpha tubulin antibody. Similar findings for 
the remaining rat, frog, and newt tissue samples can be seen in Figure 2.16B. This alpha tubulin 
blot was reprobed with the CST p21 antibody (Figure 2.16A), and none of the tested tissues 
recognized a band at approximately 21 kDa that was not previously there from exposure to the 
alpha tubulin antibody. Upon closer inspection, however, the Xenopus heart and hindlimb 
samples may show faint expression at approximately 25 kDa suggesting there could be p21 
related bands since they were not present on the initial alpha tubulin probed blot. Further 
examination will be required to determine if in fact the CST p21 antibody is recognizing a 
protein in the frog that is presumably related to p21 at approximately 25 kDa. None of the tested 
newt tissues showed p21 protein expression in response to being probed with the CST p21 
antibody. The inability to find a human or mouse anti-p21 antibody capable of cross-reacting 
with newt tissues emphasizes the need for a newt-specific p21 antibody. Moreover, the difficulty 
in finding a suitable antibody suggests that the human and newt p21 peptide sequences may be 
more distinct than previously thought.  
Discussion 
 
 This research focused on defining the temporal patterns of expression of both p21 mRNA 
and protein in the regenerating newt compared to the Murphy Roths Large mouse. The down-
regulation of this protein in MRL mice is suggested to be sufficient to confer epimorphic 
regenerative abilities in a previously non-regenerative species. Both the newt and the MRL  
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Figure 2.15: Western blot image of human neuroblastoma (SHSY5Y) cells, newt tissue, 
and zebrafish tissue samples probed with the Cell Signaling Technology anti-p21 
antibody. A) The anti-p21 antibody used at a dilution of 1/500. B) The anti-alpha tubulin 
antibody used at a 1/500 dilution. Protein from various tissues are as follows: SHSY5Y* cell 
lysate cultured with galactose as a food source, unamputated (day 0) newt tail, regenerating 
newt tail pooled from various stages, newt tail tissue injected with microRNA mimics miR1 
and miR133a, and zebrafish brain, heart, and tail tissues. The blue arrow on the right 
highlights p21 expression at approximately 20 kDa in the SHSY5Y cell sample and the 
orange arrow highlights the faint band at approximately 15 kDa that appears to be recognized 
in the zebrafish heart sample by this p21 antibody.  
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Figure 2.16: Western blot image of rat, Xenopus, and newt tissue samples probed with 
the Cell Signaling Technology anti-p21 antibody. A) The anti-alpha tubulin antibody used 
at a 1/500 dilution. B) The anti-p21 antibody used at a dilution of 1/500 and subjected to a 
higher exposure (+3) when imaging. Protein from various tissues are as follows: rat spinal 
cord, rat heart, Xenopus brain, heart, and hindlimb, and newt brain, gut, and heart. The blue 
arrow on the right highlights alpha tubulin expression at the expected molecular weight of 55 
kDa. Notably, some of the samples contain multiple bands in addition to the one at the 
predicted tubulin weight. The orange arrow denotes the presence of a single band at 
approximately 15 kDa in both Xenopus heart and hindlimb in response to probing with the 
p21 antibody. Additionally, the red arrow marks a second faint band in the Xenopus heart 
tissue sample.  
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mouse undergo epimorphic regeneration, therefore comparisons of p21 in both phenomena will 
be vital to understand the differences between these models.  
 Studies of both MRL and p21 knockout mice show that p21 protein is down-regulated, 
allowing for regeneration of lost ear tissue; however, the expression of p21 mRNA transcripts 
was never examined. In the regenerating newt, mRNA transcripts of a p21-like gene are down-
regulated at 14 and 21 days post amputation when compared to day zero p21 expression. 
Furthermore, this p21-like gene is down-regulated at 7, 14, and 21 dpa when compared to day 1 
regenerating tail tissue transcript expression. The contact between the regenerating spinal cord 
and the tail stump wound epithelium is essential for creating an environment capable of 
epimorphic regeneration (Chernoff et al., 2003). By 7 days post amputation, extensive 
breakdown of the extracellular matrix has occurred, with cells undergoing dedifferentiation and 
the formation of a wound epidermis covering the amputation site (Iten and Bryant, 1976). The 
blastema, characterized by an accumulation of proliferating cells, can be seen at day 7 with 
extensive cell proliferation detected in the ependymal cells that form a hollow terminal vesicle 
that remains continuous with the stump cord as regeneration proceeds (Benraiss et al., 1999; 
Egar and Singer, 1972). In order to be a proliferating cell population, cells will need to re-enter 
the cell cycle and be actively cycling, hence why a decrease in the expression of p21 would be 
logical at 7 days post amputation. It is, however, worth mentioning that studies of the 
regenerating axolotl limb have indicated that blastema cells undergo a ‘punctuated’ phenomenon, 
existing as a mixture of actively cycling cells and a transient quiescent population (Tassava et al., 
1987; Tomlinson et al., 1985). The composition of this mixture is dependent upon the degree of 
innervation to the limb and shifts to a primarily cycling population as regeneration proceeds 
(Tassava et al., 1987).  
 The continued, and greater down-regulation of p21-like transcripts at 14 and 21 dpa are 
suggestive of sustained extensive proliferation within the mesenchymal tail blastema that can be 
seen predominantly at 14 days post amputation. Day 14 is characterized by the formation of the 
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cartilaginous rod that is continuous with the regenerating spinal cord, growth of the accumulation 
blastema as the regenerate lengthens, and apoptosis required to clear dead cells and maintain the 
proliferative state of the regenerate (Iten and Bryant, 1976). The ependymal cells, which line the 
central canal of the spinal cord, contain numerous mitotic figures and blastema cells become 
restricted to the caudal portion of the regenerate as proliferative ependyma gives rise to new 
neurons (Chernoff et al., 2003; Iten and Bryant, 1976). By day 21, the regenerate length has 
elongated and is undergoing differentiation in a variety of tissue types. The physical changes 
occurring at 21 dpa contradict my finding of significantly decreased p21 expression at this time 
point. This disparity could indicate that the signals for differentiation in the newt tail are related 
to another gene. However, it is more likely that the gene amplified from the newt is not p21, 
instead resembling a p21-like gene, which does not exhibit the changes in p21 expression that 
would presumably occur in response to the various stages of regeneration (ie. proliferation, 
differentiation). In order to better understand this mechanism and the pattern of expression, 
examination of later time points such as 28 and 35 days post amputation would help determine 
mRNA expression of this p21-like gene throughout regeneration.   
 The observed decrease in transcript expression of the p21-like gene could be p53-
dependent as the down-regulation of p53 protein in the early stages of axolotl limb regeneration 
is necessary for blastema formation to proceed, whereas its later upregulation to baseline 
expression is necessary for redifferentiation of the limb (Yun et al., 2013). Additionally, the use 
of newt A1 myotubes to further examine this relationship determined that a decrease in p53 
activity is crucial for the postmitotic, differentiated cells to reenter the cell cycle, followed by a 
final increase in p53 to trigger muscle differentiation (Yun et al., 2013). A series of experiments 
using the p53 inhibitor, α-pifithrin, demonstrated that blocking p53 signaling significantly 
inhibits axolotl limb regeneration (Villiard et al., 2007). The p53 antibody utilized in the Villiard 
et al. (2007) study was able to successfully cross react in newt tissue and was subsequently used 
by Linklater (2011) when observing that newt A1 myotubes had basal p53 expression that 
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underwent little change post irradiation. This result was unexpected given that irradiation 
directly triggers DNA damage, and control mouse cell lines tested concurrently demonstrated 
significant changes in p53 expression in response to this stress (Linklater, 2011). These findings 
suggest that the basal expression of DNA damage proteins, like p53, may prime the cell to repair 
DNA damage accumulated as a result of the extensive proliferation required during regeneration. 
 In my study, four anti-p21 antibodies were assessed under a variety of conditions, with 
two antibodies – termed Sigma p21 and CST p21 – representing the most promising ones. The 
Sigma p21 antibody consistently recognized a low molecular weight peptide only in newt tissue 
that was later identified as CDKN2A interacting protein N-terminal like or p16 interacting 
protein. Though not p21, this result suggested that, at the very least, there are cell cycle proteins 
related to p21 present in newt tissue, and these proteins may cross-react with a p21 antibody. 
p16, also known as p16Ink4a as an inhibitor of CDK4, specifically inhibits CDK4/6 to block G1 
and cause cell cycle arrest, whereas p21 (Cip/Kip) is capable of inhibiting all cyclin/CDK 
complexes (Sherr, 1996; Tam et al., 1994). The INK4a locus, which encodes p16Ink4a and 
Alternate Reading Frame (p19ARF), is absent in lower organisms, proposed to have first arisen 
in mammals, and is thought to have evolved at the expense of regenerative capabilities (Pajcini et 
al., 2010). Homologs of p16 exist in fish such as the puffer fish, Fugu rubripes, with zebrafish 
possessing the closely-related and functionally similar gene p15 (CDK2NB), but the earliest 
(evolutionarily) identified p19ARF can be found in chickens (Gilley and Fried, 2001; Kazianis et 
al., 1999; Pajcini et al., 2010).  
 In order to test if ectopic p16 expression affects regeneration, researchers utilized Cre-
mediated induction of p16 in axolotl tails and found that spinal cord regeneration was 
suppressed, with the length of the ependymal tube being significantly reduced (Khattak et al., 
2013). Similarly, if newt A1 myotubes are injected with a plasmid containing mammalian p16, 
the cells are blocked from re-entering the cell cycle following serum treatment (Tanaka et al., 
1997). Taken together, these results suggest that the lack of p16 in salamanders creates an 
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environment conducive for robust regeneration. However, the presence of a peptide sequence in 
regenerating newt tail resembling p16-interacting protein N-terminal like does create questions 
as to why a p16-interacting protein would exist if p16 is presumably not present in the newt. 
 Upon closer examination, the CDKN2A interacting protein N-terminal like gene is 
conserved in chimp, Rhesus monkey, dog, cow, mouse, rat, zebrafish, and frog species, with a 
total of 120 organisms possessing orthologs as determined by an extensive search of NCBI. 
However, no function has been identified for this interacting protein in any organism in which it 
has been detected. Our results using the Sigma p21 antibody suggest that the p16-interacting 
protein is differentially expressed across regeneration with the greatest expression seen in 
unamputated tail, a down-regulation at 7 and 14 dpa, followed by a return to baseline levels at 21 
days post amputation (see appendix for quantification, NDay0=8 and N=5). Though not quantified 
with the required controls, this indicated pattern of expression follows a logical sequence that 
would presumably mimic the changing expression of p16 (or another CDK inhibitor) in response 
to a cell population that is re-entering the cell cycle and eventually undergoing differentiation. 
The discrepancy between p21-like mRNA transcript down-regulation at 14 and 21 dpa and the 
resurgence of p21-like protein or p16-interacting protein expression at 21 dpa, most likely 
indicates that the two experimental approaches are examining different genes and proteins, 
which has been hinted at with the discovery of the interacting protein. Further investigation into 
the novel newt p16 interacting protein is required to understand why it is present in the 
regenerating newt, and what function it performs during the regenerative process. Eventually, the 
inability of the Sigma p21 antibody to recognize the peptide for which its epitope was designed, 
despite identifying p16-interacting protein in the process, left no choice but to abandon this line 
of research, and begin testing the fourth and final antibody, CST p21.  
 Preliminary testing of the CST p21 antibody showed immediate success with recognizing 
p21 protein in the recommended positive control sample, the human neuroblastoma cell line, 
SHSY5Y (Poluha et al., 1996). This represented the first and only tested antibody to detect the 
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expression of p21 at 21 kDa in a sample, thereby validating the ability of the antibody to 
accurately identify p21 protein expression with our Western blotting procedure. When testing on 
regenerating newt tail tissue, the CST p21 antibody did not bind to any proteins. The profile of 
tissues examined was expanded to include those from the rat, zebrafish, and Xenopus, and all of 
the tested tissues, except for faint bands in Xenopus heart and hindlimb, showed no p21 
expression. Given the lack of p21 expression in newt tissue, even in the high turnover cell 
population of gut tissue which has the greatest potential to express p21, there are three main 
conclusions that can be drawn (Bouvard et al., 2000; Macleod et al., 1995). 
 First, the CST p21 antibody, like the 3 others tested, does not cross react with the newt 
and therefore is incapable of recognizing newt p21 protein expression. Second, p21 protein is 
expressed at such low levels within the tested newt tissues that it would appear to be 
undetectable using standard Western blot protocols. The use of newt total protein concentrations 
as high as 40 ug and antibody concentrations as high as 1 in 100 failed to demonstrate 
expression. Alternatively, lack of detection of p21 protein via Western blotting could be due to 
only a small proportion of cells within the regenerate actively expressing p21. The uninjured and 
regenerating newt tail both represent heterogeneous cell populations containing bone, muscle, 
fibroblasts, connective tissue, nerves, and undifferentiated cells. Examination of p21 protein in 
other species is typically performed on homogeneous cell lines, which can make it more difficult 
to extrapolate the findings back to a whole system, in vivo context, but provides a clear signal 
when probed with an anti-p21 antibody. As well, studies in wild-type mice have shown that p21 
expression can be isolated to a few select cells, making them easier to detect in tissue slices 
versus whole tissue extracts (Bouvard et al., 2000). Finally, it is possible that the newt does not 
express p21 protein, indicating that it lacks p21 similar to the MRL mouse and suggesting that 
the absence of p21 contributes to the regenerative phenotype of regeneration-competent species. 
 Testicular cells of the marbled newt, Triturus marmoratus, represent the only newt tissue 
that has been shown to express p21 protein at a molecular weight of approximately 20 kDa 
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(Ricote et al., 2002). The greatest expression of p21 is detected during the quiescent phase, at 
which point temperature and light reach the lowest values of the year, requiring little cell 
proliferation at this time (Ricote et al., 2002). The recognition of p21 in this newt tissue suggests 
that all antibodies tested in my project were simply incapable of cross reacting to newt tissue; 
however, Triturus (Triton) marmoratus, is described as one of the only newt species to lack 
regenerative capabilities. As described by Weismann in 1893, regeneration in T. marmoratus is 
minimal compared to all other species of Triton, as even slight injuries are not healed and when 
amputating an appendage or tail, the extremity failed to grow back to its original size and often 
resulted in a “deformed protuberance” (Towle, 1901; Weismann, 1893). The inability of Triturus 
marmoratus to successfully regenerate damaged tissue, combined with the strong expression of 
p21 protein, potentially explains our finding that p21 protein could not be detected in the 
regeneration-competent newt species, Notophthalmus viridescens. 
 The overall finding of changes in mRNA expression of a p21-like transcript during tail 
regeneration with no detected p21 protein expression suggests a role for potential post-
transcriptional control of p21 expression in the newt. In one study of the specific mouse tissues 
that express p21, it was determined that no direct correlation exists between the rate of mRNA 
upregulation and the number of cells expressing p21 protein, particularly in response to ionizing 
radiation damage, implicating post-transcriptional regulation (Bouvard et al., 2000). A number of 
microRNAs have been implicated in the past to regulate p21 expression at the level of 
transcription and translation (Wu et al., 1996). Research by Dolezalova et al (2012) specifically 
demonstrated that following induction of the DNA damage response via Ultraviolet-C (UVC) 
irradiation, as indicated by increased levels of p53, human embryonic stem cells (hESCs) have 
up-regulated expression of p21 mRNA, but p21 protein is not detected. Further investigation 
directly linked the miR-302 family to the regulation of p21 protein expression in hESCs 
(Dolezalova et al., 2012). Potential microRNA regulation of p21 in the newt would represent an 
additional avenue to explore in order to understand p21 expression during regeneration. 
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Although our findings parallel those of Bedelbaeva et al (2010) with a lack of p21 protein 
detected in the newt as in the regenerative MRL mouse, the further study of p21 expression in 
Notophthalmus viridescens, using such approaches as additional antibodies, histological 
examination, and in vivo functional studies, is warranted to understand the role of the cell cycle 
regulator, p21, in the regenerative process.  
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Abstract 
 
 The ability to regenerate a variety of tissues as an adult makes the newt, Notophthalmus 
viridescens, an ideal model organism to study regeneration. Mammals are typically unable to 
undergo this phenomenon of regeneration; however, the MRL mouse is able to close ear hole 
punctures through a similar mechanism. A lack of the CDK inhibitor, p21, confers regenerative 
abilities in these mice. Given that the absence of p21 is linked to MRL mouse’s ability to 
regenerate, it is imperative to determine the involvement of p21 in the newt, a regeneration-
competent species. Presently, a full-length p21 gene has not been cloned from the newt, however 
a CDK inhibitor homologous to human p21 was detected in the closely related axolotl, 
Ambystoma mexicanum. This axolotl partial contiguous sequence (contig) shares 44% identity 
with the human p21 sequence showing the greatest similarity in the CDK binding domain – the 
region considered the most highly conserved in p21 sequences across species. Following an 
extensive search that was unable to locate a p21 antibody capable of detecting the expression of 
p21 protein in the newt - assuming it is expressed in detectable quantities - the need for a newt-
specific p21 antibody was clear. In order to create this antibody, 5’-3’ Rapid Amplification of 
cDNA Ends (RACE) was performed in attempt to obtain a p21 sequence from the newt. After 
three rounds of RACE, we were unable to identify a newt-specific p21 sequence. Sequence 
information returned from the amplified products identified a high degree of similarity with p21 
from other species and the N. viridescens Histone H3a gene, unexpectedly complicating the 
process of primer design for further rounds of RACE. Despite being unable to identify a p21 
sequence from the newt, the obtained sequence data shared some similarity with p21 sequences 
from other species, but it was insufficient information to establish a significant and meaningful 
match. Therefore, these initial rounds provided important preliminary findings and suggest that 
continued pursuit of the newt-specific p21 sequence using these methods is merited.  
Introduction 
 
 The Eastern red-spotted newt, Notophthalmus viridescens, is an excellent model for 
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studying regeneration as it is the only tetrapod vertebrate capable of regenerating the spinal cord 
and limbs as an adult (Brockes and Kumar, 2003; Chernoff et al., 2003). However, in recent 
years, the difficulties in examining the molecular basis of this phenomenon due to a lack of 
genomic information have led to a decline in the use of this model organism (Bruckskotten et al., 
2012). Our own inability to ascertain if p21 protein is expressed in the newt, whether due to 
either a lack of expressed protein or unsuitable antibodies, emphasizes the necessity for a newt-
specific p21 antibody. Further to this point, the detection of a p16-interacting protein N-terminal 
like peptide sequence in regenerating newt tail, with no known record of p16 expression in the 
newt or other lower vertebrates, highlights the need for more transcriptome information made 
available by a sequenced newt genome (Abdullayev et al., 2013).  
 In order to create a newt-specific antibody, at least a partial sequence of newt p21 will be 
required and no p21 newt sequence has been identified to date. An axolotl (Ambystoma. 
mexicanum) Cip/Kip (CDK interacting protein/Kinase inhibitory protein) that is 44% identical to 
human p21 has been identified (Heber-Katz et al., 2012). Figure 3.1 shows the alignment of this 
1713bp contig with p21 protein sequences from human, two Xenopus species, and the mouse. 
This contig, or contiguous sequence, is a set of overlapping DNA segments that collectively 
represent a consensus region of DNA. The highest degree of sequence conservation exists in the 
cyclin dependent kinase (CDK)-binding domain, where two key amino acid signatures of 
LFGPVD and WNFDF exist. Outside of this defined region, there are significant sequence 
differences between the axolotl, Xenopus, and mammalian p21 sequences examined. In hopes of 
finding p21 information from another urodele, we identified a sequence in the Japanese 
salamander, Hynobius retardatus, that through BLAST searches and alignments with human 
p21, we characterized as being p21-like. Figure 3.2 depicts a pairwise alignment between the H. 
retardatus sequence and human p21 with 37% identity and 51% similarity (92% query cover, 
Evalue 4e-35, and bit score 110). When performing BLAST alignments, the combination of an 
identity greater than 30%, an E value less than 0.001, and a bit score larger than 50 are typically  
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Figure 3.1: Multiple sequence alignment comparing the axolotl p21 contig with 
known mammalian and amphibian sequences. Taken from Heber-Katz et al (2012). 
The most highly conserved region can be seen in the cyclin dependent kinase (CDK) 
binding domain. Organisms included and their associated p21 accession numbers are as 
follows: Am=Ambystoma mexicanum (axolotl) (ID: C0207013); Xl=Xenopus laevis 
(NP_001087933); Xt=Xenopus tropicalis (XP_002935823); Mm=Mus musculus 
(NP_001104569); Hs=Homo sapiens (NP_000380). 
 
 
Figure 3.2: Sequence alignment of Hynobius retardatus p21-like sequence and Human 
p21. Sequence alignment using EMBL-EBI EMBOSS Water Pairwise Protein Sequence 
Alignment program. H. retardatus p21-like sequence obtained from the DNA DataBank of 
Japan and H. sapiens p21 sequence obtained from NCBI. (|) = positions with a single, fully 
conserved residue, (:) = conservation between groups of strongly similar properties, and (.) = 
conservation between groups of weakly similar properties. 
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considered indicative of similarity, with the potential for sequence homology; however, it is 
always best to proceed cautiously when inferring functional similarities from sequence 
alignments (Pearson, 2013). Similar to the axolotl, the area of highest sequence conservation 
between the Japanese salamander and human p21 is found in the CDK-binding domain. 
Although not implicated in the regenerative response, the zebrafish, Danio rerio, has been found 
to express both p21, and the related p20, in relation to circadian cell cycle timing of both the 
brain and intestine (Laranjeiro et al., 2013; Peyric et al., 2013). Figure 3.3 illustrates the high 
degree of conservation that exists between the zebrafish p21 and p20 sequences, and a variety of 
fish, bird, and reptile species. Common domains are shared amongst the p21 and p20 sequences, 
with p20 containing a unique VPAFY amino acid signature upstream of the CDK-binding 
domain (Laranjeiro et al., 2013).    
 The lack of a published newt sequence can be partially attributed to the extremely large 
genome of Notophthalmus viridescens, with a C-value of 38 picograms and a genome size 
estimated to reach c*1010 bases, which is 10 times that of the human genome (Horner and 
Macgregor, 1983; Looso et al., 2013). The large size of the newt’s genome is a significant 
hindrance to a de novo genome project; however research groups have assembled a 
comprehensive and central repository, known as Newt-omics, to collect expressed sequence tag 
(EST) data sets in addition to microarray data and peptides identified by mass spectrometry 
(Bruckskotten et al., 2012). As well, the Sandberg lab published a reference transcriptome with 
an inferred proteome for N. viridescens from extensive RNA sequencing analyses (Abdullayev et 
al., 2013). In searching this newt transcriptome, we identified a sequence termed 84181 that 
contained the same two amino acid signatures found in a variety of other p21 sequences (Figure 
3.4). Interestingly, when directly comparing the N. viridescens 84181 p21-like and zebrafish p20 
sequences (39% identity and 53% similarity), the additional amino acid signature of p20 is 
detected in the newt sequence upstream of the CDK-binding domain, suggesting that the newt 
sequence may be more closely related to p20 instead of p21 (Figure 3.5). 
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Figure 3.3: Multiple sequence alignment comparing p20 and p21 sequences from the 
zebrafish, Danio rerio, to fish, birds, and reptiles. Taken from Laranjeiro et al (2013). 
The cyclin-binding and CDK-binding domains are the regions of greatest sequence 
conservation across species. Notably, an eleven amino acid sequence upstream of the CDK-
binding domain is highly conserved in p20 sequences and is considered the distinguishing 
factor between p21 (CDKN1A) and p20 (CDKN1D). Organisms included and their 
associated accession numbers are as follows: Zebrafish p21 (KC818434) and p20 
(KC818433); Stickleback p21 (Ensembl ID ENSGACG00000001049) and p20 (Ensembl ID 
ENSGACG00000018951); Medaka p21 (KC818436) and p20 (KC818435); Chicken p21 
(KC818438) and p20 (KC818437); Turkey p21 (Ensembl ID ENSMGAG00000013858); 
Human p21 (NP_000380). The sequences of other organisms were not specified.   
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Figure 3.4: Multiple sequence alignment of Notophthalmus viridescens p21-like sequence 
with the p21 and p20 sequences of various organisms. Sequence alignment using EMBL-
EBI EMBOSS MUSCLE Multiple Protein Sequence Alignment program. N. viridescens p21-
like sequence (84181) obtained from the Newt-omics transcriptome database. Zebrafish, 
human, and Xenopus sequences were obtained from NCBI. (*) = positions with a single, fully 
conserved residue, (:) = conservation between groups of strongly similar properties, and (.) = 
conservation between groups of weakly similar properties. 
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Figure 3.5: Sequence alignment of Notophthalmus viridescens p21-like sequence and 
Zebrafish p20. Sequence alignment using EMBL-EBI EMBOSS Water Pairwise Protein 
Sequence Alignment program. Red box highlights the conserved region between both 
sequences that matches the CDKN1D or p20-specific domain. N. viridescens p21-like 
sequence (84181) obtained from the Newt-omics transcriptome database and D. rerio p20 
sequence obtained from NCBI. (|) = positions with a single, fully conserved residue, (:) = 
conservation between groups of strongly similar properties, and (.) = conservation between 
groups of weakly similar properties. 
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 In order to resolve how p21 functions in the newt, Notophthalmus viridescens, compared 
to the regeneration-competent MRL mouse, a greater understanding of p21 in the newt is 
required. A crucial step in this process is the determination of the newt-specific p21 sequence 
given the vast differences observed in known p21 amino acid sequences, even when comparing 
closely-related species. This sequence information would also be invaluable for creating a newt-
specific p21 antibody to examine the expression of p21 protein during regeneration. The task of 
trying to identify the newt p21 sequence was completed using the technique of 5’-3’ RACE. 
Sequence information from our previously identified newt p21-like mRNA transcript, H. 
retardatus, human, axolotl, Xenopus, and the newt 84181 transcript were utilized to design 
primers for p21. After three rounds of RACE, a full p21 sequence was unable to be identified; 
however, sequence data obtained from the newt contained some similarities to established p21 
sequences, indicating the necessity for further investigation. 
Materials & Methods 
 
Animal Care and Surgery 
 
 All animal handling and surgical procedures were approved by the Brock University 
Animal Care and Use Committee. See Chapter 2 for detailed methods of caudal tail amputations 
in the adult Eastern red-spotted newt, Notophthalmus viridescens. 
5’-3’ RACE  
 
 Primers were specifically defined for separate 5’ and 3’ reactions to identify unknown 
sequence information. DNA sequences were amplified from an mRNA template between a 
defined internal site and unknown sequences of either the 3’ or 5’ ends of the mRNA. Table 3.1 
contains the primers designed for each round of RACE using Primer3. 
 Two primers are required for 5’ RACE: first, a gene specific primer (GSP1) that will 
transcribe mRNA into first strand cDNA, and second, a nested primer (GSP2), located upstream 
of GSP1 that will be used for the PCR amplification. Only one gene-specific forward primer 
(GSP1) is necessary for 3’ RACE as the natural poly-A tail of the sequence is used to prime the 
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reaction. All reactions were completed using the Roche 5’/3’ RACE Kit - 2nd Generation - 
Version 12 (Cat No. 03353621001). The 5’ reaction began with first strand cDNA synthesis with 
the GSP1 using total RNA from 7 dpa newt tail samples. Day 7 RNA was selected as it had the 
greatest concentration (ng/uL) and it produced clear bands when run on an agarose gel. It should 
be noted that previous findings (Chapter 2) indicate that p21 mRNA expression was greatest in 
unamputated tissue, with a significant decrease at 14 and 21 dpa. A general trend highlighted a 
decrease in p21 transcripts as early as day 3, potentially hindering the ability to detect p21 from 
reduced availability of transcript at 7 dpa. 
 Table 3.1: RACE Primer Sequences for each of the three rounds of 5’-3’ RACE 
performed. 
 
 Next, the Roche High Pure PCR Product Purification Kit was used to purify the single-
stranded cDNA. This purified cDNA was then submitted to Poly (A) tailing which added a 
homopolymeric A tail to the 3’ end of the first strand cDNA. Finally, PCR amplification of the 
dA-tailed cDNA was performed using the Roche Expand High Fidelity PCR System with the 
GSP2. The 3’ reaction also began with first strand cDNA synthesis using an oligo dT anchor 
primer. After this step, the cDNA was amplified directly without prior purification, utilizing the 
GSP1 primer and the Roche Expand High Fidelity PCR System. 
Product Isolation and Sequencing 
 PCR products were stored at 4°C after running RACE reactions. Samples were analyzed 
Round of 
RACE 
Primer Name Primer Sequence 
1 FORWARDGSP1 CACTTCTTCACTGCCACCTGTATC 
FORWARDGSP2 TCCTTCGACTCTCTCCTGGG 
REVERSEGSP1 GATGTCGTGGAGGTTGCAGAG 
REVERSEGSP2 CGTGGAGGTTGCAGAGGTG 
2 5PRIMEGSP1 CCATTCCAGCATGCCCACTG 
5PRIMEGSP2 AGTTCCATTTCCTGCCAGCC 
3PRIMEGSP1 ACCTTCAGCAGTTCCTTCGGA 
3 5primeGSP1p21 TCCCTCAACACCATTCCAGC 
5primeGSP2p21 GTAACCCAGCTCCTCCCATT 
3primeGSP1p21 GATCCATAACCAAGGCGAGC 
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alongside a Minisizer DNA Ladder (Norgen) on 1-2% Agarose gels containing GelRed. Bands 
were excised from each sample lane following UV visualization and DNA was extracted using a 
Gel Extraction Kit (Sigma). All samples were shipped at room temperature to Nanuq – McGill 
University and Genome Quebec Innovation Centre for sequencing service. 
Results 
 
First RACE procedure detects N. viridescens Histone H3a gene 
 Initial primer design for RACE was attempted using the partial newt p21-like sequence 
information obtained from my earlier work to confirm the identity of the qPCR product (Chapter 
2). However, the sequence length was insufficient for the primer parameters required for RACE. 
Thus, the first round of 5’-3’ RACE utilized primers specific to the axolotl p21 contig and H. 
retardatus p21-like sequences. As shown in Figure 3.6, the 5’ reaction produced a single bright 
band of approximately 400bp. Conversely, the 3’ reaction appeared as a smear on the gel 
indicating an unsuccessful amplification (results not shown). Sequencing results of the 5’ 
product indicated a high degree of similarity between the amplified DNA and the newt Histone 
H3a gene. The 5’ RACE product sequence was 86.8% identical and 87.1% similar to the 
Notophthalmus viridescens Histone H3a gene partial coding sequence (Figure 3.7).  
 This unexpected result suggested that the newt p21 sequence, for which the primers were 
originally designed, might share sequence similarity with Histone H3a. To examine this 
possibility further, a series of pairwise sequence alignments were performed between the newt 
Histone H3a protein sequence, the human p21 sequence, and four amphibian p21 sequences 
(Figure 3.8). Although matches are detected between all pairs, Figure 3.8E shows that the axolotl 
p21 sequence shares the highest degree of similarity to the newt Histone H3a with 41.2% identity 
and 52.9% similarity. When performing a BLAST alignment, this translates to 16% query cover 
with 39% identity (E value 0.018 and bit score 19.2), indicating that despite sharing some similar 
amino acids, there is insufficient sequence information to identify the 5’ RACE product as p21-
like. Based upon these findings, it was imperative for the second round of primer design that  
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Figure 3.6: 5’ RACE product from 1st RACE reaction after being subjected to agarose 
electrophoresis and UV irradiation. The arrow denotes 5’ product excised for sequencing 
purposes. Norgen DNA Minisizer ladder indicates the product is approximately 400bp in 
length. The lower bands in the 5’ product most likely represent artifacts caused by the 
nonspecific binding of primers to multiple primer sites or primer dimers and therefore, were 
not included in the analysis (SMARTer RACE Kit product information). 
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Figure 3.7: Sequence alignment of N. viridescens 5’RACE product and N. viridescens 
Histone H3a gene. Sequence alignment using EMBL-EBI EMBOSS Water Pairwise Protein 
Sequence Alignment program. N. viridescens histone H3a sequence obtained from NCBI after 
BLAST search with 5’RACE product. (|) = positions with a single, fully conserved residue, (:) 
= conservation between groups of strongly similar properties, and (.) = conservation between 
groups of weakly similar properties. 
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Figure 3.8: Multiple pairwise sequence alignments of Notophthalmus viridescens Histone 
H3a and p21 sequences from human and a variety of amphibians. Sequence alignment 
using EMBL-EBI EMBOSS Water Pairwise Protein Sequence Alignment program. N. 
viridescens p21-like sequence (84181) obtained from the Newt-omics transcriptome database. 
Axolotl p21 sequence obtained from SalSite database. H. retardatus p21-like sequence 
obtained from the DNA DataBank of Japan. N. viridescens Histone H3a sequence and p21 
sequences from Xenopus and human obtained from NCBI. (|) = positions with a single, fully 
conserved residue, (:) = conservation between groups of strongly similar properties, and (.) = 
conservation between groups of weakly similar properties. 
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both the 5’ and 3’ sequences would target p21, while minimizing the likelihood of recognizing 
and binding to the Histone H3a sequence as well. 
Second round of RACE recognizes C. elegans sequences 
 The task of designing p21-specific primers proved to be a difficult process, requiring that 
the 3’ reaction be run at two different annealing temperatures in order to find the optimal 
temperature to increase specificity and minimize the potential of the primers dimerizing. The 
final 3’ product can be seen in Figure 3.9. As indicated by the blue arrows to the right, the 3’ 
RACE reaction underwent a step-wise sequencing process in which the sequence information 
from each smaller band was nested in the larger band directly above it. All five of the bands 
present in the sample were collected for sequencing. The presence of nested sequences was 
confirmed when reviewing the sequence chromatograms from Nanuq and observing that the 
sequence data from each of the smaller excised bands was contained in the larger bands above. 
The 5’ reaction ran on the gel as a very bright smear and was excluded from this round of 
analysis.  
 Sequencing results from this round of RACE identified all of the 3’ RACE products as C. 
elegans related sequences using BLAST (see appendix). The largest sequence fragment, of 
approximately 300 base pairs shares 95% identity with a C. elegans genome assembly complex; 
98% identity with a C. elegans fosmid, which is an artificially constructed cloning vector based 
on a bacterial F plasmid; and 95% identity with a C. elegans uncharacterized protein. 
Interestingly, when trying to understand why the 3’ RACE product was only recognizing C. 
elegans sequences when p21-specific primers were utilized, an alignment of the Hynobius 
retardatus p21 sequence with the 3’ product determined that they shared identity and similarity 
of 45.4%. Follow-up with a BLAST alignment found that with 63% query coverage the two 
sequences are 28% identical (E value 1.2 and bit score 13.1) indicating that the sequence 
similarity is just below the recommended 30% threshold. Figure 3.10 shows the pairwise 
alignment of the H. retardatus p21 sequence and the 3’ RACE product, and suggests that  
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Figure 3.9: 3’ RACE product from 2nd RACE reaction after being subjected to agarose 
electrophoresis and UV irradiation. Lane 1 contains a 5’ RACE product that returned no 
sequence information. Lane 2 contains a 3’ RACE product. The arrows indicate the stepwise 
sequencing of the 3’ product in a series of nested fragments later excised for sequencing 
purposes. Norgen DNA Minisizer ladder indicates the 3’ products range from 100 to 
approximately 300 bp.  
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Figure 3.10: Sequence alignment of N. viridescens 3’RACE product and H. retardatus 
p21. Sequence alignment using EMBL-EBI EMBOSS Water Pairwise Protein Sequence 
Alignment program. H. retardatus p21-like sequence obtained from the DNA DataBank of 
Japan. (|) = positions with a single, fully conserved residue, (:) = conservation between 
groups of strongly similar properties, and (.) = conservation between groups of weakly 
similar properties. 
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although the sequence only returned results related to C. elegans, the sequence might contain 
more p21-like characteristics than previously thought. 
Final round of RACE produces bright bands on the gel, but no sequence information found 
 After two unsuccessful rounds of RACE reactions trying to determine the newt p21 
sequence, the final primer design process targeted the CDK-binding domain of the human p21 
sequence and focused on those areas of this region that were most similar to the axolotl, H. 
retardatus, and newt transcriptome sequences. As can be seen in Figure 3.11, both the 5’ and 3’ 
RACE reactions resulted in products with bright bands on the gel that were isolated for 
sequencing. Unfortunately, no sequence information was returned from any of the samples. 
Another round of samples was sent for sequencing using the remainder of the PCR products 
from this third set of reactions, but once again no useful sequence information was returned. 
Discussion 
 
 Perhaps one of the most challenging aspects of working with the Eastern Red Spotted 
newt, Notophthalmus viridescens, as a model organism is the fact that it remains largely 
unsequenced. In order to identify the newt p21 sequence, it was necessary to use the p21 
sequences of related species to design the 5’ and 3’ RACE primers. The comparison of the newt 
transcriptome 84181 and the zebrafish p20 sequences suggested that the unidentified newt 
sequence could be more closely related to p20 (CDKN1D) than p21 (CDKN1A). In the 
zebrafish, p20 expression is independent of p53 expression, implying that its role as a cell cycle 
regulator differs from that of the closely-related p21 (Laranjeiro et al., 2013). Further study of 
the newt transcriptome sequence will be required to determine if it can be formally identified as 
either p20 or p21. 
 The first round of RACE reactions, which resulted in an almost 400 base pair product 
resembling the newt Histone H3a gene, represented a good starting point for this new technique. 
Although not the product expected, the high degree of similarity between the p21 sequences and 
Histone H3a, which was unknown before this point, suggests that the amplified product might be  
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Figure 3.11: 3’ and 5’ RACE products from 3rd RACE reaction after being subjected to 
agarose electrophoresis and UV irradiation. Lane 1 contains the 5’ RACE product. Lane 2 
contains the 3’ RACE product. Blue arrows denote the 3’ products excised for sequencing 
purposes at approximately 225 and 100 base pairs. The Norgen DNA Minisizer ladder 
indicates the 5’ products, highlighted with green arrows, are less than 100bp in length. 
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p21-like, it just also shares relatedness to newt histone. As well, while this has no bearing on the 
actual sequence of histone H3a and how it relates to p21, it is interesting to note that 
phosphorylated histone H3 has been used in a variety of regenerative studies as a marker for 
mitotic cells (Albors et al., 2015; Love et al., 2013; Tseng et al., 2007; Tweedell, 2010).  
 The second round of RACE leading primarily to C. elegans sequences from BLAST 
searches could be linked to the fact that databases lack sufficient newt-specific sequences to 
compare these products against. All of the C. elegans sequences were associated with unknown 
proteins or assemblages that contain large amounts of unassigned and unidentified sequence 
information. The 45.4% identity and similarity detected between the Hynobius retardatus p21 
sequence and the 3’ RACE product indicate that the sequence data obtained from this reaction 
might contain p21-like characteristics that require additional comparison to known p21 
sequences. 
 The final round of RACE showed the greatest promise of p21 sequence information when 
visualizing the bright bands on the gel; however, no sequence data was obtained from the 
products. The lack of data from these samples was concerning given that the procedures 
performed had been successful in the past, and PCR product that was not subjected to gel 
electrophoresis and excision, sent to control for the experimental conditions, failed to provide 
any quality sequence information. The inability to retrieve sequence information from the 
samples on the second attempt was not unexpected given that only 10 ul of each sample 
remained to be run on the gel and typically at least 20 ul of sample is used to aid in band 
isolation.  
 Taken together, the results from three rounds of 5’-3’ RACE indicate that the amplified 
products contained sequence information related to p21 in the newt based upon their similarity to 
p21 sequences from a variety of organisms. Following the creation of new primers, perhaps 
including ones that focus on the amino acid signature related to zebrafish p20, additional rounds 
of RACE should be performed to gather more sequence information from the newt in hopes of 
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determining the newt-specific p21 sequence.  
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 Following my study, the role of the cell cycle regulator, p21, in newt tail and caudal 
spinal cord regeneration still remains unknown. It was found that a p21-like transcript is down-
regulated in regenerating newt tail at 14 and 21 dpa compared to unamputated tissue, with a 
trend of decreased expression as early as 3 days post amputation (Figure 2.1). Sequencing 
analysis performed on the qPCR product revealed similarity with the axolotl p21 contig, 
suggesting the amplified product was p21-like. This small sequence fragment was then utilized 
as a starting point for determining the newt-specific p21 sequence using 5’-3’ RACE. The 
difficulties associated with detecting p21 protein expression in the newt made efforts to sequence 
the newt p21 gene an important part of this project. Even though none of the sequence 
information returned from 5’-3’ RACE was directly identified as p21 through BLAST searches, 
similarities between the products and p21 sequences from the axolotl, human, Xenopus, and 
Japanese newt, suggest that the newt amplified products have p21-like features and warrant 
additional rounds of RACE analysis (Figure 3.8).  
 In the process of searching for an antibody capable of identifying newt p21 expression, 
four separate antibodies were tested. The first two antibodies failed to recognize any of the 
recommended mammalian samples, making them unusable for detecting p21 expression. The 
third antibody tested was chosen from Sigma-Aldrich because the epitope sequence targeted a 
portion of the human p21 CDK-binding domain - the region bearing the greatest similarity 
between human and axolotl p21 sequences (Heber-Katz et al., 2012). Across all samples tested, 
this Sigma antibody failed to recognize p21 expression at the predicted weight of 21 kDa. 
However, a low molecular weight band of approximately 14-16 kDa was detected in both newt 
tail and limb over the course of regeneration (Figures 2.5, 2.6, and 2.8). This low molecular 
weight band was expressed in unamputated tissue, with a down-regulation seen at both 7 and 14 
dpa, followed by a return of expression to almost basal levels by 21 days post amputation.  
 Protein identification analysis of this low molecular weight band revealed that it 
contained, among other proteins, the cell cycle related protein: CDKN2A N-terminal like 
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interacting protein or p16-interacting protein (Figures 2.10 and 2.11). Further testing of this 
antibody was unable to detect p21 expression in any control sample, leading to the use of a 
fourth and final p21 antibody. The CST p21 antibody was the only tested antibody to 
successfully detect p21 protein expression in one of the recommended control cell lines 
(SHSY5Y neuroblastoma cells), thereby validating the antibody and Western blotting techniques 
(Figure 2.14). A variety of newt, rat, Xenopus, and zebrafish tissues were tested with the CST 
p21 antibody, but p21 expression was not detected in any of the samples (Figures 2.15 and 2.16).  
 Collectively, this work represents a the first attempt to examine the expression of the cell 
cycle regulator, p21, during tail and caudal spinal cord regeneration in the newt, Notophthalmus 
viridescens. Results from qPCR analysis indicate that the down-regulation of a p21-like gene 
coincides temporally with some of the morphological and cellular changes occurring in the tail 
over the course of regeneration. Despite evidence for expression of the p21-like transcript, no 
protein could be detected. This could be due to a lack of p21 protein expression in the newt, 
similar to the MRL mouse, but the use of a newt-specific p21 antibody would be a definitive way 
to determine the expression of p21 during regeneration. The continued use of 5’-3’ RACE to 
identify the newt-specific p21 sequence will be vital to this effort. The novel finding of a p16-
interacting protein, which is differentially expressed across regeneration, represents a prospective 
new research avenue into the existence and role of p16 during regeneration. p16 is thought to 
have first arose in mammals and has not been found in salamanders, suggesting that the lack of 
p16 may be related to the robust regenerative capacities of urodeles (Khattak et al., 2013; Pajcini 
et al., 2010). Axolotl, Xenopus, and zebrafish all possess the gene for CDKN2A N-terminal like 
interacting proteins, but the functionality of this p16-interacting protein has yet to be determined. 
Ultimately, my investigation of p21 in caudal spinal cord and tail regeneration provides a 
foundation for future studies of the relationship between cell cycle regulation and regeneration in 
the newt.  
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Perspectives 
 
 The original aim of this thesis was to determine the role that the cell cycle regulator p21 
plays in the regenerative process of the regeneration-competent species, Notophthalmus 
viridescens. After extensive attempts to find an antibody capable of cross-reacting in the newt, it 
became clear that this task would be much more difficult than originally thought. Despite testing 
a variety of tissue types, antibody and protein concentrations, incubation times and temperatures, 
secondary antibodies, and detection systems, I was unable to detect p21 protein in the newt in 
any of the tissues at any time points, used. When assessing these findings, some important future 
considerations come to mind.  
 First, it may be advantageous to attempt to detect p21 protein expression directly from 
caudal spinal cord and tail tissue sections rather than whole tissue protein extracts. Previous 
work in the mouse to establish the cellular localization of p21 expression determined that on 
several occasions, only a few cells in one particular region expressed p21 at any given point in 
time (Bouvard et al., 2000). This could be a similar situation in the newt, perhaps causing the 
combination of different tissues and cells in one extract to dilute the p21 signal. As a preliminary 
approach, fluorescence in situ hybridization (or FISH) could utilize probes matching the primers 
that recognized a p21-like transcript in newt homogenates. This procedure would allow for the 
identification of the transcripts in vivo and may facilitate determining where the p21 protein 
should be expressed. The majority of the antibodies I tested in this study were specifically 
designed solely for Western blotting applications, but the CST p21 antibody, which was the only 
antibody to recognize positive control samples, is suitable for immunofluorescence purposes. 
The next step in testing this antibody would be to collect a series of unamputated and 
regenerating newt tail histological sections, if FISH results detected p21 transcript expression, 
and incubate them with the CST p21 antibody to try and visualize p21 within the cells directly.  
 Second, my research also involved several attempts to perform comet assays to examine 
the degree of single and double strand breaks in newt DNA; however, technical issues prevented 
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continued pursuit of the project. The comet assay is a rapid and sensitive method for detecting 
the presence of both single and double strand DNA breaks by applying a current across a mini 
agarose gel containing a cell suspension on a microscope slide (Hartmann et al., 2003). The cells 
are exposed to a lysis solution and if strand breaks are present, the DNA loops out, eventually 
being pulled in one direction by the applied current, causing a ‘comet’ that is indicative of DNA 
damage. Work by Bedelbaeva et al (2010) demonstrated extensive single and double stranded 
DNA breaks in the MRL mouse compared to wild-type mice using comet assays, indicating that 
the regenerative ability comes at the expense of increased DNA damage. The DNA damage 
response is triggered upon detection of damage, leading to the activation of the oncogene p53 
and subsequently stimulating p21 expression in order to prevent further progression of the cell 
cycle (Dolezalova et al., 2012). Given that I was unable to detect expression of p21 protein in the 
newt under normal conditions, one suggestion would be to expose newts to irradiation or 
carcinogens for the purpose of triggering this cascade and provoking the expression of p21. A 
similar study was undertaken by Linklater (2011) to determine the expression of p53 in 
Notophthalmus viridescens in response to DNA damage, finding that a basal level of p53 was 
detected with virtually no change post irradiation. Interestingly, when MRL mice were exposed 
to gamma irradiation, no change in the expression of p21 was observed, indicating that even in 
response to DNA damage, the expression of p21 was not induced (Bedelbaeva et al., 2010). It 
will be of interest to see if p21 expression exhibits a similar pattern as p53 in the newt or as p21 
in the MRL mouse.  
 More sensitive than the comet assay, the use of immunoblotting or immunostaining to 
examine the expression of phosphorylated histone H2AX (γH2AX) is the ideal way to assess 
DNA damage (Sharma et al., 2012). As a widespread marker of DNA damage, γH2AX directly 
reflects the extent of DNA damage as foci are formed within seconds of double strand break 
induction and a subsequent decrease in foci is observed as the DNA is repaired (Sharma et al., 
2012). Previously, staining with γH2AX was significantly increased in the MRL mouse and in 
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newt A1 myotubes exposed to UV irradiation, indicating the presence of DNA damage 
(Bedelbaeva et al., 2010; Yun et al., 2013).  
 Third, the difficulties associated with detecting p21 protein strongly suggest the need for 
a newt-specific p21 antibody. As mentioned previously, the only instance of p21 expression in a 
newt was detected in the testicular tissue of Triturus marmoratus marmoratus (Ricote et al., 
2002). The protein showed differential expression across the annual testicular cell cycle with the 
greatest levels observed during the quiescent period. However, T. marmoratus is unique since it 
is one of the only urodele amphibians that has limited regenerative ability (Towle, 1901; 
Weismann, 1893). This finding could be of interest if the strong expression of p21 is related to 
its lack of regenerative ability, as the absence of p21 confers regenerative capabilities in the 
MRL mouse. After contacting the researchers directly, we obtained the Santa Cruz p21 antibody 
utilized in their study. A preliminary test of this antibody utilized unamputated and regenerating 
newt tail, newt gut, heart, and brain, and SHSY5Y neuroblastoma cells. The expression of p21 
was not detected in any of the tested tissues mirroring the previous results obtained with the 
other four antibodies. Although not shown to work with this antibody directly, SHSY5Y cells 
were utilized given their prior success as a positive control sample with the CST p21 antibody. A 
more appropriate positive control in this instance would be T. marmoratus testes tissue that has 
been shown to have a 21kDa protein recognized by this antibody. The next step will involve 
repeating this Western blot procedure in order to optimize the new antibody, as well as trying to 
obtain Triturus marmoratus marmoratus gonadal as well as limb and tail tissue to be able to 
directly test it alongside Notophthalmus viridescens tissue to compare and confirm the results of 
Ricote et al (2002).  
 Finally, there is the ultimate consideration of using other regeneration-competent species 
to determine the role of cell cycle regulators like p21 in the regenerative process. Zebrafish 
represent an excellent model organism, as they are also capable of undergoing extensive 
regeneration that occurs through a similar epimorphic phenomenon. The mRNA expression of 
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both p21 and p20 has been established in the brain and intestine, leaving the expression of p21 
and p20 protein expression and the role of both CDK inhibitors in zebrafish regeneration 
unknown (Laranjeiro et al., 2013). As well, the use of Xenopus adults and tadpoles would allow 
for a comparative analysis of p21 expression through the changing regenerative capacity that 
occurs as the frog undergoes metamorphosis. The opportunity to examine these two regeneration 
competent species, in addition to the newt, would allow for a more comprehensive study of the 
role of p21 in regeneration-competent species and could aid in determining if a lack of p21 
protein expression is in fact a key characteristic associated with the ability to regenerate.
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Appendix 
 
1) Laemmli Buffer Recipe 
a. 5 mL 0.5M Tris HCl, pH 7.0 (3.49g Tris HCl and dH2O up to 50mL) 
b. 5 mL dH2O 
c. 1.2 g SDS 
d. 4 mL glycerol 
e. 2 mL bromophenol blue solution (1 mg bromophenol blue in 1 mL dH2O – store 
at room temperature) 
f. 620 mg dithiothreitol (DTT) 
2) Protein Lysis Buffer Recipe 
a. 150 mM NaCl (5M stock) à 300 uL 
b. 50 mM Tris HCl pH 7.5-7.6 (1M stock) à 500 uL 
c. 10 mM EDTA (0.5M stock) à 200 uL 
d. 1 mL of 10% Triton X-100 
e. 100 uL of 100mM PMSF 
f. 100 uL of protease inhibitor cocktail (Sigma) 
g. 7.8 mL of MilliQ  
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Figure A1: Western blot of frog, rat, and newt tissues probed with the Sigma p21 
Antibody. The anti-p21 antibody used at a concentration of 5 ug/mL. Protein (40ug) from 
various tissues are as follows: frog liver tissue, rat liver tissue, pooled unamputated newt limb 
tissue, and two biological replicates of unamputated (day zero) newt tail tissue. The arrow on 
the right highlights a low molecular weight band recognized by the Sigma anti-p21 antibody 
at 14/15 kDa in only newt tail tissue. 
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Figure A2: Western blot of newt tail tissues probed with the Sigma p21 Antibody. (A) 
The anti-p21 antibody used at a concentration of 5 ug/mL. (B) The anti-alpha tubulin antibody 
used at a 1/500 dilution. Protein (20 ug) from various tissues are as follows: unamputated (day 
zero) newt tail tissue and newt tail regenerate tissue from days 7, 14, and 21 dpa. The arrow 
on the right highlights a low molecular weight band recognized by the Sigma anti-p21 
antibody at 14/15 kDa in all newt tail tissue samples. 
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Figure A3: Western blot of newt tail tissues probed with the Sigma p21 Antibody and 
later reprobed with the anti-alpha tubulin antibody. The anti-p21 antibody used at a 
concentration of 5 ug/mL and the anti-alpha tubulin antibody used at a 1/500 dilution. Protein 
(20 ug) from various tissues are as follows: unamputated (day zero) newt tail tissue and newt 
tail regenerate tissue from days 7, 14, and 21 dpa. The lower arrow on the right highlights a 
low molecular weight band recognized by the Sigma anti-p21 antibody at 14/15 kDa in all 
newt tail tissue samples. The upper arrow on the right highlights alpha tubulin expression at 
55 kDa in all newt tail tissue samples. 
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Figure A4: Western blot of newt tail tissues probed with the Sigma p21 Antibody. (A) 
The anti-p21 antibody used at a concentration of 5 ug/mL. (B) The anti-alpha tubulin antibody 
used at a 1/500 dilution. Protein (12 ug) from various tissues are as follows: three biological 
replicates of unamputated (day zero) newt tail tissue and newt tail regenerate tissue from days 
7, 14, and 21 dpa. The arrow on the right highlights a low molecular weight band recognized 
by the Sigma anti-p21 antibody at 14/15 kDa in all newt tail tissue samples. This blot was 
incubated in a blocking serum made of 5% BSA instead of 3% Milk powder, producing 
brighter and cleaner bands that required less exposure for imaging. 
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Figure A5: Western blot of SHSY5Y cells and newt tail tissues probed with the Sigma 
p21 Antibody. The anti-p21 antibody used at a concentration of 5 ug/mL. Protein (15 ug) 
from various tissues are as follows: two cell lysates from SHSY5Y cells cultured in media 
containing galactose, unamputated (day zero) newt tail tissue, and newt tail regenerate tissue 
from days 7, 14, and 21 dpa. The arrow on the right highlights a low molecular weight band 
recognized by the Sigma anti-p21 antibody at 14/15 kDa in all newt tail tissue samples and 
the SHSY5Y cell lysate samples.  
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Figure A7: Quantification of Mean Band Density of low molecular weight band 
recognized in newt limb tissues by the Sigma p21 antibody. Significant differences are 
seen between day 0 and day 14 newt tail tissues and day 14 and day 21 newt tail tissues. N=2 
for all time points, F=20.21, p value=0.0070; *<0.05, **<0.01. 
 
Figure A6: Quantification of Mean Band Density of low molecular weight band 
recognized in newt tail tissues by the Sigma p21 antibody. Significant differences are seen 
between day 0 and day 7 newt tail tissues and day 0 and day 14 newt tail tissues. There is also 
a significant difference in band density detected between day 14 and day 21 newt tails. 
NDay0=8 and N=5 for all other time points, F=10.47, p value=0.0003; *<0.05, **<0.01, 
***<0.001. 
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Figure A8: Quantification of Mean Band Density for ERK expression. (A) Band densities 
are similar across all newt tail time points tested (N=1). (B) No significant differences are seen 
between day 7, 14, and 21 newt tail tissues (N=2), suggesting that ERK expression is consistent 
across regenerative time points.  
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Figure A9: Western blot of SHSY5Y cells and newt tail tissues probed with the CST p21 
Antibody. (A) The anti-p21 antibody used at a dilution of 1/500. (B) The anti-alpha tubulin 
antibody used at a 1/500 dilution. Protein (25 ug) from various tissues are as follows: two cell 
lysates of SHSY5Y cells cultured in media containing galactose, two biological replicates of 
unamputated (day zero) newt tail tissue, two biological replicates of 24 hour regenerate newt 
tail tissue, and newt tail regenerate tissue from 48 and 72 hours post amputation. The arrow 
on the right highlights p21 expression at approximately 20 kDa in only the SHSY5Y cell 
lysate samples.  
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Figure A10: Western blot of SHSY5Y cells and newt tail tissues probed with the CST 
p21 Antibody. (A) The anti-p21 antibody used at a dilution of 1/500. (B) The anti-alpha 
tubulin antibody used at a 1/500 dilution. Protein (40 ug) from various tissues are as follows: 
two cell lysates of SHSY5Y cells cultured in media containing galactose, two biological 
replicates of unamputated (day zero) newt tail tissue, and newt tail regenerate tissue from 24 
and 72 hours post amputation. The arrow on the right highlights p21 expression at 
approximately 20 kDa in only the SHSY5Y cell lysate samples. 
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Figure A11: Ponceau-stained blot Western blot and imaged blot of various newt tissues 
and SHSY5Y cell lysate samples probed with the DSHB Alpha Tubulin Antibody. (A) 
Ponceau-stained image of Western blot before incubation with the primary antibody to stain 
for all proteins and validate that transfer was efficient. (B) Western blot image of anti-alpha 
tubulin antibody used at a 1/500 dilution and imaged as a negative using the BioRad GelDoc 
system. Protein (15 ug) from various tissues are as follows: newt tail tissue from 0, 24, 48, 
and 72 hours post amputation, newt tail tissue from 7, 14, and 21 days post amputation, 
pooled day 0 (unamputated) newt limb tissue, and a cell lysate from SHSY5Y cells cultured 
in media with galactose. This blot demonstrates that the transfer procedure was efficient, and 
that even low molecular weight proteins were effectively transferred.  
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Figure A12: Western blot in Figure A10 of SHSY5Y cells and newt tail tissues probed 
with the CST p21 Antibody now reprobed with DSHB Alpha Tubulin Antibody. The 
anti-p21 antibody used at a 1/500 dilution and the anti-alpha tubulin antibody used at a 1/500 
dilution. Protein (40 ug) from various tissues are as follows: two cell lysates of SHSY5Y cells 
cultured in media containing galactose, three biological replicates of unamputated (day zero) 
newt tail tissue, and newt tail regenerate tissue from 24 and 72 hours post amputation. The 
lower arrow on the right highlights p21 expression at approximately 20 kDa in only the 
SHSY5Y cell lysate samples. The upper arrow on the right highlights alpha tubulin 
expression at 55 kDa in all of the tested samples indicating that protein was successfully re-
probed on the same blot and that protein samples were not degraded. 
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Figure A13: BLAST results finding that the 3’RACE product from primers designed to 
target p21 shares a high degree of similarity with 3 sequences from C. elegans. A) 
3’RACE product shows 98% identity with C. elegans genome assembly complex. B) 3’ 
RACE product shows 98% identity with C. elegans fosmid. A fosmid is an artificially 
constructed cloning vector, like a cosmid, but is based on the bacterial F plasmid. C) 3’ RACE 
product shows 98% identity with the uncharacterized protein syp-4. 
 
